<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60660</article-id><article-id pub-id-type="doi">10.7554/eLife.60660</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>The linear ubiquitin chain assembly complex (LUBAC) generates heterotypic ubiquitin chains</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-241053"><name><surname>Rodriguez Carvajal</surname><given-names>Alan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8340-8620</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-240097"><name><surname>Grishkovskaya</surname><given-names>Irina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199564"><name><surname>Gomez Diaz</surname><given-names>Carlos</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6416-806X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177677"><name><surname>Vogel</surname><given-names>Antonia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199565"><name><surname>Sonn-Segev</surname><given-names>Adar</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-240098"><name><surname>Kushwah</surname><given-names>Manish S</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-199566"><name><surname>Schodl</surname><given-names>Katrin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199567"><name><surname>Deszcz</surname><given-names>Luiza</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199568"><name><surname>Orban-Nemeth</surname><given-names>Zsuzsanna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199569"><name><surname>Sakamoto</surname><given-names>Shinji</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2480-2940</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-48667"><name><surname>Mechtler</surname><given-names>Karl</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-9461"><name><surname>Kukura</surname><given-names>Philipp</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-52566"><name><surname>Clausen</surname><given-names>Tim</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1582-6924</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-154164"><name><surname>Haselbach</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5276-5633</contrib-id><email>david.haselbach@imp.ac.at</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-14174"><name><surname>Ikeda</surname><given-names>Fumiyo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0407-2768</contrib-id><email>fumiyo.ikeda@bioreg.kyushu-u.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC)</institution><addr-line><named-content content-type="city">Vienna</named-content></addr-line><country>Austria</country></aff><aff id="aff2"><label>2</label><institution>Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC)</institution><addr-line><named-content content-type="city">Vienna</named-content></addr-line><country>Austria</country></aff><aff id="aff3"><label>3</label><institution>Department of Chemistry, University of Oxford, Chemistry Research Laboratory</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution>Pharmaceutical Frontier Research Labs, JT Inc.</institution><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff><aff id="aff5"><label>5</label><institution>Medical Institute of Bioregulation (MIB), Kyushu University</institution><addr-line><named-content content-type="city">Fukuoka</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Wolberger</surname><given-names>Cynthia</given-names></name><role>Senior Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Martin</surname><given-names>Andreas</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>06</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e60660</elocation-id><history><date date-type="received" iso-8601-date="2020-07-02"><day>02</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-06-17"><day>17</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Rodriguez Carvajal et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Rodriguez Carvajal et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60660-v2.pdf"/><abstract><p>The linear ubiquitin chain assembly complex (LUBAC) is the only known ubiquitin ligase for linear/Met1-linked ubiquitin chain formation. One of the LUBAC components, heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L), was recently shown to catalyse oxyester bond formation between ubiquitin and some substrates. However, oxyester bond formation in the context of LUBAC has not been directly observed. Here, we present the first 3D reconstruction of human LUBAC obtained by electron microscopy and report its generation of heterotypic ubiquitin chains containing linear linkages with oxyester-linked branches. We found that this event depends on HOIL-1L catalytic activity. By cross-linking mass spectrometry showing proximity between the catalytic RING-in-between-RING (RBR) domains, a coordinated ubiquitin relay mechanism between the HOIL-1-interacting protein (HOIP) and HOIL-1L ligases is suggested. In mouse embryonic fibroblasts, these heterotypic chains were induced by TNF, which is reduced in cells expressing an HOIL-1L catalytic inactive mutant. In conclusion, we demonstrate that LUBAC assembles heterotypic ubiquitin chains by the concerted action of HOIP and HOIL-1L.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>E3 ubiquitin ligase</kwd><kwd>HOIL-1L</kwd><kwd>oxyester-bond linkage</kwd><kwd>RBR</kwd><kwd>ubiquitin</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP 18K19959</award-id><principal-award-recipient><name><surname>Ikeda</surname><given-names>Fumiyo</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP 21H04777</award-id><principal-award-recipient><name><surname>Ikeda</surname><given-names>Fumiyo</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>JP 21H00288</award-id><principal-award-recipient><name><surname>Ikeda</surname><given-names>Fumiyo</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001822</institution-id><institution>Austrian Academy of Sciences</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ikeda</surname><given-names>Fumiyo</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001003</institution-id><institution>Boehringer Ingelheim</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Clausen</surname><given-names>Tim</given-names></name><name><surname>Haselbach</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>FFG</institution></institution-wrap></funding-source><award-id>852936</award-id><principal-award-recipient><name><surname>Clausen</surname><given-names>Tim</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>PHOTOMASS 819593</award-id><principal-award-recipient><name><surname>Kukura</surname><given-names>Philipp</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The E3 ubiquitin ligase complex linear ubiquitin chain assembly complex (LUBAC) forms a branched chain on linear ubiquitin chains depending on the RING-in-between-RING-type E3 ligase heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L).</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Posttranslational modification of substrates with ubiquitin (ubiquitination) regulates a wide variety of biological functions. Ubiquitin forms chains via its seven internal Lys residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63) through an isopeptide bond, or via Met1 through a peptide bond (<xref ref-type="bibr" rid="bib34">Komander and Rape, 2012</xref>). The different ubiquitin chain types contribute to determine the fate of the substrate and biological outcomes regulated.</p><p>For substrate modification, ubiquitin can be conjugated through isopeptide bonds to Lys residues, thioester bonds formed with the side chain of Cys residues, or oxyester bonds formed with side chains of Ser and Thr residues (<xref ref-type="bibr" rid="bib4">Carvalho et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">McClellan et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">McDowell and Philpott, 2013</xref>; <xref ref-type="bibr" rid="bib72">Vosper et al., 2009</xref>; <xref ref-type="bibr" rid="bib75">Wang et al., 2007</xref>; <xref ref-type="bibr" rid="bib76">Williams et al., 2007</xref>). In addition, some bacteria have evolved a ubiquitination mechanism, carried out by proteins of the SidE effector family, that results in phosphoribosyl-linked ubiquitin conjugated to Ser residues of the protein substrate (<xref ref-type="bibr" rid="bib58">Shin et al., 2020</xref>; <xref ref-type="bibr" rid="bib2">Bhogaraju et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Qiu et al., 2016</xref>). Ubiquitin also contains seven Thr (Thr7, Thr9, Thr12, Thr14, Thr22, Thr55, and Thr66) and three Ser (Ser20, Ser57, and Ser65) residues that could potentially act as sites for chain formation. Recently, ubiquitin polymerization through Ser or Thr residues by a mammalian RING-in-between-RING (RBR)-type ubiquitin ligase, heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L), has been described (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>). The E3 ligase MYCBP2 was also shown to conjugate the ubiquitin to Thr residues through an ester bond (<xref ref-type="bibr" rid="bib46">Pao et al., 2018</xref>). Besides these examples, all other known instances of ubiquitin-associated (UBA) oxyester bonds are found in the linkage between the ubiquitin and a non-ubiquitin substrate (<xref ref-type="bibr" rid="bib40">McClellan et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">McDowell and Philpott, 2013</xref>).</p><p>HOIL-1L is a component of the linear ubiquitin chain assembly complex (LUBAC). LUBAC is thus far the only known E3 ubiquitin ligase complex that assembles linear/Met1-linked ubiquitin chains. LUBAC consists of two RBR-containing proteins: HOIL-1-interacting protein (HOIP) and HOIL-1L (<xref ref-type="bibr" rid="bib33">Kirisako et al., 2006</xref>). LUBAC additionally contains the accessory protein Shank-associated RH domain-interacting protein (SHARPIN) (<xref ref-type="bibr" rid="bib24">Gerlach et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Ikeda et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Tokunaga et al., 2011</xref>). HOIP has a catalytic centre in its RING2 domain responsible for assembly of linear ubiquitin chains, while HOIL-1L and SHARPIN have been recognized as accessory proteins for the process. It is more recent that HOIL-1L has been shown to catalyse ubiquitination (<xref ref-type="bibr" rid="bib46">Pao et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Stieglitz et al., 2012</xref>; <xref ref-type="bibr" rid="bib61">Smit et al., 2013</xref>; <xref ref-type="bibr" rid="bib66">Tatematsu et al., 2008</xref>). Linear ubiquitin chains and the three LUBAC components are essential components in biological functions including immune signalling (<xref ref-type="bibr" rid="bib24">Gerlach et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Ikeda, 2015</xref>; <xref ref-type="bibr" rid="bib50">Rahighi et al., 2009</xref>; <xref ref-type="bibr" rid="bib51">Rittinger and Ikeda, 2017</xref>; <xref ref-type="bibr" rid="bib68">Tokunaga et al., 2009</xref>; <xref ref-type="bibr" rid="bib30">Iwai and Tokunaga, 2009</xref>), development in mice (<xref ref-type="bibr" rid="bib22">Fujita et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Peltzer et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Peltzer et al., 2014</xref>), protein quality control (<xref ref-type="bibr" rid="bib70">van Well et al., 2019</xref>), Wnt signalling (<xref ref-type="bibr" rid="bib52">Rivkin et al., 2013</xref>), and xenophagy (<xref ref-type="bibr" rid="bib45">Noad et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">van Wijk et al., 2017</xref>). Therefore, it is important to understand how LUBAC assembles ubiquitin chains at the molecular level including how the catalytic activity of HOIL-1L contributes to the process.</p><p>In a recent study, Kelsall et al. demonstrated that recombinant HOIL-1L can polymerize ubiquitin via oxyester bonds on Ser and Thr. They also showed that a HOIL-1L C458S mutation in which a predicted ubiquitin-loading site is mutated results in reduction of oxyester-linked ubiquitination signals in cells suggesting their dependency on HOIL-1L (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>). Moreover, Fuseya et al. recently demonstrated that HOIL-1L catalytic activity negatively regulates the TNF signalling cascade (<xref ref-type="bibr" rid="bib23">Fuseya et al., 2020</xref>). However, understanding the precise mechanisms regulating this atypical form of ubiquitination and whether HOIL-1L as a part of LUBAC mediates this biochemical activity remains largely unresolved.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Reconstitution and 3D reconstruction of LUBAC</title><p>We first set out to purify high-quality recombinant LUBAC for structural characterization and biochemical investigation. Purifications of the three LUBAC components expressed individually in <italic>Escherichia coli</italic> consistently gave low yields and isolated proteins were co-purified with several contaminants; this was particularly severe in purifications of full-length HOIP (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Given that HOIP is destabilized in cells lacking SHARPIN or HOIL-1L (<xref ref-type="bibr" rid="bib24">Gerlach et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Ikeda et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Tokunaga et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Fujita et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Peltzer et al., 2018</xref>), we conjectured that HOIP could be unstable when recombinantly expressed in the absence of its interaction partners. To this end, we expressed HOIP (119.8 kDa), N-terminally His-tagged HOIL-1L (59.2 kDa), and N-terminally Strep(II)-tagged SHARPIN (43.0 kDa) in insect cells in order to co-purify the LUBAC holoenzyme by tandem affinity chromatography. Using this co-expression strategy, we were able to isolate three proteins of the expected molecular weights with no major contaminants as determined by SDS-PAGE followed by Coomassie staining (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Furthermore, we verified the identities of these proteins as the three LUBAC components by immunoblotting indicating the successful isolation of recombinant LUBAC (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Some truncation products of HOIP were detected by immunoblotting; however, these were not visible by Coomassie-based staining, indicating that they are not a prominent contaminant.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Co-expression and purification of linear ubiquitin chain assembly complex (LUBAC) yields high-quality protein.</title><p>(<bold>A</bold>) SDS-PAGE analysis of individually purified LUBAC components. (<bold>B</bold>) SDS-PAGE analysis of co-expressed and purified LUBAC. (<bold>C</bold>) Immunoblot analysis of co-purified LUBAC.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Gel filtration analysis of linear ubiquitin chain assembly complex (LUBAC) showing presence of multiple populations with different oligomeric states.</title><p>(<bold>A</bold>) Gel filtration profile of purified LUBAC separated over S200 column. (<bold>B</bold>) Tandem gel filtration separation of fraction 3 re-run over S200 column. (<bold>C</bold>) Molecular weight standards separated over S200 column.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To examine the stability of the purified complexes, we performed gel filtration chromatography (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). The elution profile of the complex contained two peaks eluting at 0.942 ml (peak I) and 0.972 ml (peak II) as well as one minor peak eluting at 1.158 ml (peak III). All of these peaks eluted earlier than the 158 kDa molecular weight standard, which eluted at 1.246 ml (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). Given that the monomeric mass of purified LUBAC is expected to be 222 kDa, the elution profile suggests that these peaks all correspond to assembled LUBAC in at least three populations of different oligomeric states. However, while peaks I and II contained all LUBAC components, peak III contained predominantly HOIL-1L and SHARPIN (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, lower panel) indicating the presence of partially assembled complexes. To assess if this was a carryover from the purification or if the complex disassembles over time, we collected a fraction from peak II and reapplied it to the same column for a second isocratic elution (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). The elution profile from this second tandem run contained almost exclusively peaks I and II, which correspond to assembled LUBAC (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>, lower panel). Conversely, peak III was almost entirely absent from the elution profile indicating that the complex is not prone to dissociation after purification.</p><p>To screen the homogeneity of the sample, we imaged fractions from peak II by negative staining electron microscopy. Micrographs show a monodisperse distribution of particles of similar size, which could be sorted into 2D class averages showing a distinct elongated dumbbell structure thus verifying the homogeneity of the sample (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Furthermore, we were able to generate the first low-resolution 3D reconstruction of LUBAC from these particles (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). In accordance with the class averages, the model displays an elongated asymmetric crescent structure with the majority of the mass concentrated at one end. The class averages match calculated projections of the generated model very well showing that the model is self-consistent. (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>First low-resolution 3D map of linear ubiquitin chain assembly complex (LUBAC) obtained by negative staining electron microscopy of the recombinant complex.</title><p>(<bold>A</bold>) Representative negative stain transmission electron micrograph of recombinant LUBAC. Scale bar: 100 nm. (<bold>B</bold>) 3D refined model of LUBAC obtained by single particle analysis of negative stained electron micrographs. (<bold>C</bold>) LUBAC 2D class averages matched to projections made from 3D refined map. (<bold>D</bold>) Mass photometry measurements of LUBAC indicate formation of a ternary complex with 1:1:1 stoichiometry that can form dimers.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Modelling of the linear ubiquitin chain assembly complex (LUBAC) by negative staining electron microscopy.</title><p>(<bold>A</bold>) LUBAC 2D class averages obtained from negatively stained particles. (<bold>B</bold>) Initial 3D model of LUBAC made from particles picked in negatively stained electron micrographs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Projections made from 3D refined model of linear ubiquitin chain assembly complex (LUBAC).</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Independent mass photometry measurements of linear ubiquitin chain assembly complex (LUBAC).</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig2-figsupp3-v2.tif"/></fig></fig-group><p>Collectively, we established a purification protocol to obtain high-purity and high-quality recombinant LUBAC that allowed us to generate the first low-resolution 3D reconstruction of the complex, from which we find the volume of structural envelope is approximately consistent with a 230 kDa particle.</p></sec><sec id="s2-2"><title>LUBAC exists as monomers and dimers with a 1:1:1 stoichiometry between HOIP, HOIL-1L, and SHARPIN</title><p>The precise stoichiometry and oligomerization state of LUBAC have not been established although recent structural work has suggested a 1:1:1 stoichiometry between the three core components (<xref ref-type="bibr" rid="bib22">Fujita et al., 2018</xref>). To determine the stoichiometry and oligomerization state of LUBAC, we used mass photometry (MP), a technique that enables accurate mass measurements based on the scattering of light by single macromolecules in solution (<xref ref-type="bibr" rid="bib79">Young et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Sonn-Segev, 2019</xref>; <xref ref-type="fig" rid="fig2">Figure 2D</xref> and <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). MP measurements showed that the majority of species present in the samples had average masses of 231 kDa (peak II) and 454 kDa (peak III) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). An additional peak originating from a population with mass of less than 100 kDa was also measured (peak I), which could arise from isolated HOIL-1L or SHARPIN present in the measured sample.</p><p>With respect to the expected mass of the ternary LUBAC, the populations of peaks II and III nearly correspond with monomers (222 kDa) and dimers (444 kDa) of LUBAC with a 1:1:1 stoichiometry between HOIP, HOIL-1L, and SHARPIN.</p></sec><sec id="s2-3"><title>The RBR domains of HOIP and HOIL-1L are in close proximity</title><p>Understanding the precise mechanistic action of HOIL-1L and SHARPIN within LUBAC requires knowledge of structural and functional domain interactions between the three components. Current knowledge of the interaction domains of HOIP, HOIL-1L, and SHARPIN is shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref>. Structural work of protein fragments has shown that HOIL-1L and SHARPIN interact with HOIP through their respective ubiquitin-like (UBL) domains, which bind cooperatively to the HOIP UBA domain (<xref ref-type="bibr" rid="bib22">Fujita et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Yagi et al., 2012</xref>; <xref ref-type="fig" rid="fig3">Figure 3A</xref>). By using truncation mutants, it has also been shown that the SHARPIN UBL domain interacts with the Npl zinc finger 2 (NZF2) domain of HOIP (<xref ref-type="bibr" rid="bib28">Ikeda et al., 2011</xref>). More recently, structural work has revealed that SHARPIN and HOIL-1L interact with each other through their respective LUBAC-tethering motifs (LTMs) (<xref ref-type="bibr" rid="bib22">Fujita et al., 2018</xref>). Otherwise, there is no further information available about the overall spatial arrangement of the domains of HOIP, HOIL-1L, and SHARPIN.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Cross-linking mass spectrometry (MS) analysis shows proximity between the catalytic domains of HOIL-1-interacting protein (HOIP) and heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L).</title><p>(<bold>A</bold>) Schematic representation of linear ubiquitin chain assembly complex (LUBAC) components with their domains and known interactions. (<bold>B</bold>) Circos plot of inter-protein cross-links formed between LUBAC components. (<bold>C</bold>) Detected inter-protein cross-links formed between HOIL-1L and HOIP. (<bold>D</bold>) Detected inter-protein cross-links formed between HOIL-1L and Shank-associated RH domain-interacting protein (SHARPIN). (<bold>E</bold>) Detected inter-protein cross-links formed between HOIP and SHARPIN.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig3-v2.tif"/></fig><p>To obtain more detailed information about the spatial arrangement of LUBAC components, we performed cross-linking mass spectrometry (XL-MS) experiments. For this purpose, we used the amine-to-carboxyl-reactive cross-linker, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium tetrafluoroborate (DMTMM), a zero-length cross-linker (<xref ref-type="bibr" rid="bib36">Leitner et al., 2014</xref>) revealing Lys and Asp/Glu contacts that are adjacent to each other. As shown in <xref ref-type="fig" rid="fig3">Figure 3B–E</xref>, we observed an extensive network of intra-protein and inter-protein cross-links, providing a detailed picture of LUBAC assembly (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary files 2</xref> and <xref ref-type="supplementary-material" rid="supp3">3</xref>).</p><p>We detected some highly cross-linking residues that formed cross-links indiscriminately to all subunits of all proteins. These were HOIL-1L K174, SHARPIN K318, and HOIP K454/458. The high degree of cross-linking formed by these residues suggests that they are located on flexible regions. This notion is supported by the cleavage of HOIL-1L in the vicinity of K174 by MALT1, which suggests that the residue is located on a protease-accessible structure such as a flexible loop (<xref ref-type="bibr" rid="bib12">Elton et al., 2016</xref>). The presence of flexible regions on the three LUBAC components may be related to the difficulties in determining the structures of full-length HOIP, HOIL-1L, and SHARPIN thus far.</p><p>We also observed DMTMM cross-links between LUBAC domains known to interact, such as between the HOIL-1L UBL and the SHARPIN UBL/LTM domains as well as between the HOIP UBA and HOIL-1L LTM domains, several cross-links pointed to new connections between the engaged proteins. Interestingly, we observed cross-links between the HOIL-1L RING1 and HOIP RING1/LDD domains, as well as between the HOIL-1L RING2 and the HOIP RING1/IBR/RING2/LDD domains, which suggest that the two enzymes have spatially connected catalytic activities. Additionally, HOIL-1L intra-protein cross-links were formed between its NZF domain and its RING1/IBR/RING2 domains, which could implicate the HOIL-1L NZF domain of unknown function in the catalytic action of HOIL-1L. In conclusion, the catalytic RBR domains of HOIP and HOIL1L seem to be close to each other, as well as the NZF and RBR regions of HOIL-1L. These data suggest that LUBAC may have a single catalytic centre containing the RBR domains of HOIP and HOIL-1L.</p></sec><sec id="s2-4"><title>Recombinant LUBAC assembles heterotypic ubiquitin chains containing linear and non-Lys linkages</title><p>To assess the ability of recombinant LUBAC to assemble linear ubiquitin chains, we performed in vitro ubiquitination assays. As expected, LUBAC generated linear ubiquitin chains in an ATP-dependent manner (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We also observed additional signals derived from co-purified LUBAC, which were absent from reactions containing the three individually purified and mixed LUBAC components (<xref ref-type="fig" rid="fig4">Figure 4B</xref>: red arrows).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Linear ubiquitin chain assembly complex (LUBAC) assembles heterotypic poly-ubiquitin chains containing M1 and non-Lys linkages in vitro.</title><p>(<bold>A</bold>) Time course of co-purified LUBAC in vitro ubiquitin chain assembly reaction. (<bold>B</bold>) Comparison of in vitro chain assembly between HOIL-1-interacting protein (HOIP), heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L), and Shank-associated RH domain-interacting protein (SHARPIN) mixed at 1:1:1 molar ratio versus co-purified LUBAC. (<bold>C</bold>) LUBAC in vitro chain assembly using different ubiquitin K to R mutants. (<bold>D</bold>) LUBAC in vitro chain assembly using K0 ubiquitin. (<bold>E</bold>) Ubiquitin chain restriction (UbiCRest) analysis of poly-ubiquitin chains assembled by LUBAC in vitro. All experiments were performed in triplicate representative results are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Anti-linear ubiquitin antibody validation.</title><p>(<bold>A</bold>) Detection of mono-ubiquitin and di-ubiquitin of different linkages by anti-linear ubiquitin antibody. (<bold>B</bold>) Detection of longer Lys48 and Lys63-linked ubiquitin chains by anti-linear ubiquitin antibody.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Independently purified HOIL-1-interacting protein (HOIP), heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L), and Shank-associated RH domain-interacting protein (SHARPIN) mixed at an equimolar ratio cannot reconstitute the trimeric linear ubiquitin chain assembly complex (LUBAC).</title><p>Independent mass photometry (MP) measurements and weighted average made from HOIP, HOIL-1L, and SHARPIN mixed to a final concentration of 4 pM of each protein.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig4-figsupp2-v2.tif"/></fig></fig-group><p>The exclusive appearance of extra bands in the co-purified LUBAC sample indicates that the complex does not attain its full catalytic activity in vitro when the three LUBAC components are mixed. One possible explanation is that mixing of the three components is sufficient to activate HOIP but may not suffice for LUBAC to be adequately assembled. To determine if the mixed components could assemble the trimeric LUBAC, we carried out MP measurements of the three components mixed at an equimolar ratio (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Our measurements showed a single prominent population of molecules with an average mass of 104 kDa. However, we were unable to detect any populations with the expected masses of 222 or 444 kDa corresponding to assembled and dimerized LUBAC. The absence of these populations indicates that mixing HOIP, HOIL-1L, and SHARPIN does not suffice to assemble LUBAC. We therefore conclude that the absence of bands in reactions carried out using mixed LUBAC components is a result of improper LUBAC assembly preventing the full catalytic activity of the complex.</p><p>Ubiquitin chains containing different linkages resolve at different apparent molecular masses by SDS-PAGE separation (<xref ref-type="bibr" rid="bib13">Emmerich and Cohen, 2015</xref>). Therefore, we hypothesized that the two bands in each pair contained different ubiquitin linkages. To examine the presence of different Lys-linked bonds in the heterotypic chains, we carried out in vitro ubiquitination assays using different ubiquitin Lys to Arg (KR) mutants (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Heterotypic ubiquitin chain assembly was observed with all the tested mutants, K6R, K11R, K27R, K29R, K33R, K48R, and K63R. To rule out the possibility that mutation of a single Lys could be compensated by ubiquitination of a separate Lys residue, we also performed in vitro ubiquitination assay using ubiquitin lacking all Lys residues (K<sub>0</sub>) (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Despite reduced reaction efficiency, the K<sub>0</sub> mutant could also be used by LUBAC to generate the heterotypic ubiquitin chains. At present we cannot account for the apparent difference in the ratio between branched tri- and tetra-ubiquitin chains observed across different experiments, and which is particularly pronounced with the K<sub>0</sub> substrate. However, we speculate that these differences arise from varied reaction efficiencies. We propose this is the case given that branched tri-ubiquitin is the more prominent species when K<sub>0</sub> ubiquitin is used. With this mutant we also observe a drastic loss of overall reaction efficiency with respect to reactions containing wild-type (WT) ubiquitin. Nevertheless, both branched chains could be detected to some extent across all replicates of all experiments.</p><p>To further analyse the linkage types of ubiquitin chains, we performed ubiquitin chain restriction (UbiCRest) (<xref ref-type="bibr" rid="bib27">Hospenthal et al., 2015</xref>) on the ubiquitin chains generated by LUBAC (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). UbiCRest using linkage-specific deubiquitinases (DUBs) allows detection of specific ubiquitin chains by loss of signals when the linkage is targeted. Interestingly, the additional signals from ubiquitin chains assembled by LUBAC disappeared by treatment with Cezanne, a DUB specific for the Lys11 linkage (<xref ref-type="bibr" rid="bib3">Bremm et al., 2010</xref>); or vOTU, a DUB targeting Lys linkages (<xref ref-type="bibr" rid="bib1">Akutsu et al., 2011</xref>; <xref ref-type="fig" rid="fig4">Figure 4E</xref>; upper red arrow). The linear linkage-specific DUB OTULIN (<xref ref-type="bibr" rid="bib20">Fiil et al., 2013</xref>) hydrolysed all linear ubiquitin bonds (<xref ref-type="fig" rid="fig4">Figure 4E</xref>: upper panel), corresponding to most of the ubiquitin signal, but left non-linear di- and tri-ubiquitin residues (<xref ref-type="fig" rid="fig4">Figure 4E</xref>: lower panel).</p><p>These data collectively indicate that recombinant LUBAC assembles heterotypic ubiquitin chains containing predominantly linear linkage with non-Lys-linked branches.</p></sec><sec id="s2-5"><title>LUBAC assembles heterotypic poly-ubiquitin chains containing linear and ester-linked bonds in vitro and in cells</title><p>A recent study showed that recombinant HOIL-1L can generate di-ubiquitin linked via an oxyester bond in vitro and can also ubiquitinate substrates through oxyester bonds in cells (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>). Therefore, we tested for the presence of oxyester bonds in the ubiquitin chains by checking their sensitivity to the nucleophile hydroxylamine (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Treatment with hydroxylamine resulted in the disappearance of the upper band of the linear tetra-ubiquitin chain (<xref ref-type="fig" rid="fig5">Figure 5A</xref>: red arrow). This indicates that the chain branching is achieved by formation of an oxyester bond between ubiquitin moieties similar to the observation in the previous study (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Linear ubiquitin chain assembly complex (LUBAC) assembles heterotypic poly-ubiquitin chains containing M1 and ester bond linkages at T12 and T55.</title><p>(<bold>A</bold>) Treatment of LUBAC-assembled heterotypic poly-ubiquitin chains with hydroxylamine. (<bold>B</bold>) Hydroxylamine treatment of ubiquitin polymers assembled by LUBAC using N-terminally blocked ubiquitin. (<bold>C</bold>) MS/MS spectra of ubiquitin polymerized at T55 (top) and T12 (bottom). Poly-ubiquitin chains assembled by LUBAC were separated by SDS-PAGE, bands were cut from the gel and subjected to mass spectrometry analysis. (<bold>D</bold>) Positions of Thr12 and Thr55 on structure of ubiquitin (PDB:1UBI). (<bold>E</bold>) Assembly of ubiquitin chains by LUBAC using different ubiquitin Thr to Val point mutants as substrates. All experiments were performed in triplicate representative results are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Cezanne, vOTU, and hydroxylamine can cleave oxyester bonds in linear ubiquitin chain assembly complex (LUBAC)-assembled heterotypic ubiquitin chains.</title><p>(<bold>A</bold>) Combined OTULIN and hydroxylamine treatment of LUBAC-assembled poly-ubiquitin chains. (<bold>B</bold>) Cezanne and vOTU ubiquitin chain restriction (UbiCRest) analysis of ubiquitin polymers assembled by LUBAC using N-terminally blocked ubiquitin.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig5-figsupp1-v2.tif"/></fig></fig-group><p>To further ascertain whether LUBAC assembles ester-linked ubiquitin polymers, we carried out in vitro ubiquitination assays using N-terminally His<sub>6</sub>-tagged ubiquitin, which cannot be used to assemble linear ubiquitin chains (<xref ref-type="bibr" rid="bib33">Kirisako et al., 2006</xref>). LUBAC inefficiently assembled di- and tri-ubiquitin chains with His-ubiquitin, which are sensitive to hydroxylamine treatment (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). These results demonstrate that when the N-terminus of ubiquitin is not available, LUBAC can still assemble oxyester-linked poly-ubiquitin even in the absence of linear ubiquitin chains.</p><p>To determine if LUBAC was generating any other kind of ubiquitin linkage other than linear and oxyester bonds, we treated LUBAC-assembled ubiquitin chains with OTULIN and hydroxylamine (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Restriction with OTULIN degraded the majority of the signal from ubiquitin chains leaving short di- and tri-ubiquitin polymers. Subsequent treatment with hydroxylamine resulted in complete degradation of the poly-ubiquitin signals. These results indicate that LUBAC assembles exclusively OTULIN-sensitive linear and hydroxylamine-sensitive oxyester linkages between ubiquitin moieties.</p><p>In our UbiCRest analysis we observed cleavage of the oxyester-linked branches from the LUBAC-assembled poly-ubiquitin chains by Cezanne and vOTU (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Therefore, we also tested the sensitivity of the exclusively oxyester-linked ubiquitin chains assembled by LUBAC with His<sub>6</sub>-ubiquitin to the two DUBs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Both Cezanne and vOTU could fully degrade these short oxy-ester ubiquitin polymers, which is in agreement with a recent study reporting the ester-directed activity of the two DUBs (<xref ref-type="bibr" rid="bib7">De Cesare et al., 2021</xref>).</p><p>Ubiquitin contains seven Thr residues, three Ser residues, and one Tyr residue, which could theoretically act as sites for ester bond formation. Therefore, we aimed to identify the positions of the ester-linked branches using mass spectrometry by searching for GG dipeptides covalently attached through oxyester bonds to Ser, Thr, or Tyr, as was previously done by <xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>. To this end, we analysed ubiquitin chains formed by LUBAC by LC-MS. MS/MS spectra of GG-conjugated dipeptides at residues Thr12 and Thr55 of ubiquitin were detected from these samples, in which there was complete coverage of the ubiquitin amino acid sequence 1–73 (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Structural analysis shows that these two residues are positioned at opposite sides of ubiquitin and neither of them is located in proximity to Met1 or the C-terminal Gly76 (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; PDB:1UBI). This suggests that branches could potentially exist on both sites of a single ubiquitin molecule located at any position of a linear ubiquitin chain without creating any steric hindrances.</p><p>To further investigate if Thr12 and Thr55 are the sites of oxyester bond formation, we performed in vitro ubiquitination assays using ubiquitin mutated at Thr12 and/or Thr55 to Val (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Individual or concomitant mutation of Thr12 and Thr55 (Ub T<sub>12</sub>V, Ub T<sub>55</sub>V, or Ub T<sub>12/55</sub>V, respectively) did not result in loss of chain branching. These results suggest that linear chain branching is not a strictly site-specific event. We next probed the existence of the hybrid chains in cells. It has recently been reported that these chains are formed on IRAK1, IRAK2, and Myd88 in response to activation of TLR signalling (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>). Given that LUBAC is involved in the TNF signalling cascade, we examined the induction of these heterotypic ubiquitin chains in TNF-treated cells. Linear ubiquitin chains were enriched by GST pull-down using the NEMO-UBAN and zinc finger domains (NEMO<sub>250-412</sub>) from total cell extracts of TNF stimulated mouse embryonic fibroblasts (MEFs). In this set-up, the GST-NEMO-UBAN was employed as a ubiquitin-binding matrix to enrich linear-linked chains and not as a substrate for LUBAC. The enriched poly-ubiquitin chains were then tested for hydroxylamine sensitivity (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). TNF stimulation increased formation of linear ubiquitin chains detected by immunoblotting using an antibody specific for linear ubiquitin chains (<xref ref-type="fig" rid="fig6">Figure 6A</xref>: PD top panel lane 7). These chains proved sensitive to hydroxylamine treatment (<xref ref-type="fig" rid="fig6">Figure 6A</xref>: PD top panel lane 8). In contrast, the signals from the overall population of ubiquitin chains are unchanged by either TNF stimulation or hydroxylamine treatment (<xref ref-type="fig" rid="fig6">Figure 6A</xref>: PD bottom panel lanes 5–8). Together these results suggest that ubiquitin chains containing both linear linkages and hydroxylamine-sensitive ester bonds are produced in cells in response to TNF stimulation.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>M1-linked/linear ubiquitin chains generated in cells and conjugated to NEMO in vitro are sensitive to hydroxylamine treatment.</title><p>(<bold>A</bold>) Hydroxylamine treatment of M1 linkage-containing poly-ubiquitin chains assembled in response to TNF in wild-type (WT) mouse embryonic fibroblasts (MEFs). MEFs were treated with TNF for 15 min and lysed, lysates were subjected to GST PD using GST or GST-NEMO(250-412), beads were treated with buffer or hydroxylamine for 30 min, bound ubiquitin species were then analysed by immunoblotting. (<bold>B</bold>) Treatment of linear ubiquitin chain assembly complex (LUBAC)-dependent NEMO in vitro ubiquitination reactions with hydroxylamine. All experiments were performed in triplicate representative results are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig6-v2.tif"/></fig><p>To determine if substrate-conjugated linear-linked ubiquitin chains are also branched, we carried out an in vitro ubiquitination assay using NEMO as the substrate then subjected the products to hydroxylamine treatment (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Treatment of ubiquitinated NEMO with the compound resulted in enrichment of some lower molecular weight bands corresponding to ubiquitinated NEMO when blotting with a NEMO-specific antibody. However, the majority of the signal from the ubiquitinated NEMO was unperturbed. These results suggest that the conjugation of ubiquitin chains to the substrate is principally through hydroxylamine-resistant isopeptide bonds with some hydroxylamine-sensitive chain branching or substrate ubiquitination also taking place on longer linear chains.</p></sec><sec id="s2-6"><title>HOIP assembles linear ubiquitin chains that are subsequently branched with ester bonds by HOIL-1L</title><p>We next proceeded to probe how HOIP and HOIL-1L generate these heterotypic ubiquitin chains. HOIP specifically assembles linear ubiquitin chains through the action of its RBR domains wherein Cys885 is the catalytic residue (<xref ref-type="bibr" rid="bib60">Smit et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">Stieglitz et al., 2013</xref>); similarly HOIL-1L catalyses ester bond-directed ubiquitination via its RBR domain where Cys460 is the catalytic site (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>; <xref ref-type="bibr" rid="bib61">Smit et al., 2013</xref>). Therefore, we examined the possibility that HOIP assembles a linear ubiquitin chain, which is subsequently branched with ester bonds by HOIL-1L. To this end, we purified different LUBAC containing catalytically inactive HOIP (HOIP C885A), HOIL-1L (HOIL-1L C460A), or both HOIP C885A and HOIL-1L C460A. Mutation of these residues did not impair the purification of LUBAC, and all variants of the complex could be isolated at similar yields and to similar degrees of purity (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). In line with our hypothesis, LUBAC containing HOIL-1L C460A generated chains with linear linkages, yet the double band indicative of heterotypic chain assembly was absent (<xref ref-type="fig" rid="fig7">Figure 7A</xref>; lane 6 upper red arrow). These observations indicate that HOIL-1L is responsible for the formation of the ester-linked branches. Consistent with previous reports (<xref ref-type="bibr" rid="bib61">Smit et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Fuseya et al., 2020</xref>), HOIP assembled longer linear ubiquitin chains in the absence of HOIL-1L catalytic activity and did so more rapidly (<xref ref-type="fig" rid="fig7">Figure 7A</xref>: lanes 2 and 6). Conversely, LUBAC containing HOIP C885A was incapable of polymerizing ubiquitin altogether (<xref ref-type="fig" rid="fig7">Figure 7A</xref>; lanes 4 and 8) as expected. These results suggest that HOIL-1L catalytic activity disturbs linear ubiquitin chain formation but requires HOIP catalytic activity.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L) generates ester linkages on heterotypic chains but requires HOIL-1-interacting protein (HOIP) catalytic activity to polymerize ubiquitin.</title><p>(<bold>A</bold>) Comparison of linear ubiquitin chain assembly complex (LUBAC) in vitro chain assembly by complexes containing different catalytically inert mutants of HOIP and HOIL-1L. (<bold>B</bold>) OTULIN restriction of poly-ubiquitin chains assembled by LUBAC containing wild-type (WT) or catalytically inert HOIL-1L. (<bold>C</bold>) Hydroxylamine treatment of M1 linkage-containing poly-ubiquitin chains assembled in response to TNF in WT and <italic>Rbck1<sup>C458A/C458A</sup></italic> mouse embryonic fibroblast (MEF) cells. Cells were treated with TNF (50 ng/ml) for 15 min and lysed, lysates were subjected to GST PD using GST-NEMO (250-412), beads were treated with buffer or hydroxylamine for 30 min, bound ubiquitin species were then analysed by immunoblotting. (<bold>D</bold>) Schematic representations of different HOIL-1L mutants. (<bold>E</bold>) Comparison of LUBAC in vitro chain assembly by complexes containing different HOIL-1L mutants. All experiments were performed in triplicate representative results are shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Purification of linear ubiquitin chain assembly complex (LUBAC) containing catalytically inert HOIL-1-interacting protein (HOIP) and heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L) proteins.</title><p>(<bold>A</bold>) SDS-PAGE analysis of different purified LUBAC. (<bold>B</bold>) Immunoblot analysis of different purified LUBAC.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Generation of <italic>Hoil-1l<sup>C458A/C458A</sup></italic> mice.</title><p>(<bold>A</bold>) Sequences of genomic DNA around C458 codon, gRNAs, and donor oligonucleotide used to target heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L) C458A mutation. (<bold>B</bold>) Sanger sequencing confirming correct mutations at target sites. (<bold>C</bold>) Genotyping results of <italic>Hoil-1l<sup>+/+</sup></italic>, <italic>Hoil-1l<sup>+/C458A</sup></italic>, and <italic>Hoil-1l<sup>C458A/C458A</sup></italic> mice. Hpy188III digest of a PCR fragment confirming correct targeting where a silent mutation is inserted. (<bold>D</bold>) Immunoblot analysis of linear ubiquitin chain assembly complex (LUBAC) component expression in mouse embryonic fibroblasts (MEFs) derived from <italic>Hoil-1l<sup>+/+</sup></italic> and <italic>Hoil-1l</italic><sup>C458A/C458A</sup> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig7-figsupp2-v2.tif"/></fig></fig-group><p>The gel-migration pattern differed between ubiquitin chains assembled by LUBAC with HOIL-1L C460A and the WT complex (<xref ref-type="fig" rid="fig7">Figure 7A</xref>: lanes 2 and 6). Therefore, we compared the presence of non-linear bonds in the chains assembled by the different complexes by OTULIN. The restriction analyses showed that the ubiquitin chains assembled by LUBAC contained non-linear di- and tri-ubiquitin chains, whereas chains assembled by HOIL-1L C460A-containing LUBAC generated exclusively OTULIN-sensitive linear ubiquitin chains (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). These results further support the claim that chain branching is dependent on the catalytic action of HOIL-1L while HOIP exclusively assembles linear ubiquitin chains.</p></sec><sec id="s2-7"><title>HOIL-1L catalytic activity is required for branched ubiquitin chain formation in cells</title><p>To further study the catalytic function of HOIL-1L in cells, we used cells derived from a HOIL-1L C458A knock-in mouse (<italic>Rbck1<sup>C458A/C458A</sup></italic>) generated by CRISPR/Cas9 gene-editing technology (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2A–C</xref>). The expression levels of the three LUBAC components are similar in MEFs in <italic>Rbck1<sup>+/+</sup></italic> and <italic>Rbck1<sup>C458A/C458A</sup></italic> MEFs (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2D</xref>). In agreement with numerous studies from the past, two species of HOIL-1L were detected in <italic>Rbck1<sup>+/+</sup></italic> MEFs by immunoblotting; the slower migrating species originating from auto-ubiquitinated HOIL-1L was absent in <italic>Rbck1<sup>C458A/C458A</sup></italic> MEFs.</p><p>To determine if HOIL-1L is the responsible ligase for linear ubiquitin chain branching during TNF signalling, TNF-treated <italic>Rbck1<sup>C458A/C458A</sup></italic> MEF lysates were subjected to GST pull-down with GST-NEMO<sub>250-412</sub> followed by hydroxylamine treatment (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Similarly, to WT MEFs, TNF stimulation led to an increase in the levels of linear ubiquitin chains in <italic>Rbck1<sup>C458A/C458A</sup></italic> MEFs (<xref ref-type="fig" rid="fig7">Figure 7C</xref>: PD top panel lanes 3 and 7). However, the enriched ubiquitin signals detected by immunoblotting revealed a higher basal level of linear ubiquitin chains in <italic>Rbck1<sup>C458A/C458A</sup></italic> MEFs compared to those in <italic>Rbck1<sup>+/+</sup></italic> MEFs (<xref ref-type="fig" rid="fig7">Figure 7C</xref>: PD top panel lanes 1 and 5). Moreover, unlike in <italic>Rbck1<sup>+/+</sup></italic> MEFs, linear ubiquitin chains in <italic>Rbck1<sup>C458A/C458A</sup></italic> MEFs were not sensitive to degradation by hydroxylamine treatment (<xref ref-type="fig" rid="fig7">Figure 7C</xref>: PD bottom panel). However, there was no obvious difference when blotting for general ubiquitin between <italic>Rbck1<sup>+/+</sup></italic> and <italic>Rbck1<sup>C458A/C458A</sup></italic> MEFs regardless of TNF stimulation or chain hydroxylamine treatment (<xref ref-type="fig" rid="fig7">Figure 7C</xref>: PD bottom panel). These results show that ester-linked branching of linear ubiquitin chains formed during TNF signalling in MEFs is dependent on the catalytic activity of HOIL-1L.</p></sec><sec id="s2-8"><title>HOIL-1L Npl4 zinc finger is involved in the formation of branching ubiquitin chains in vitro</title><p>Since the catalytic action of HOIP precedes that of HOIL-1L and the assembly of linear ubiquitin chains precedes the appearance of the branches, we hypothesized that HOIL-1L interacts with a linear ubiquitin chain as a substrate for branching via its linear ubiquitin chain-specific binding domain NZF (<xref ref-type="bibr" rid="bib54">Sato et al., 2011</xref>). To test this possibility, we purified LUBAC containing a mutant in which critical residues for linear ubiquitin chain recognition are mutated (HOIL-1L T203A,R210A) (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). In agreement with our hypothesis, chain branching activity by LUBAC was partially impaired by the HOIL-1L T203A,R210A mutant when compared to the WT or HOIL-1L C460A (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). Interestingly, LUBAC with HOIL-1L T203A,R210A assembled ubiquitin chains more efficiently than WT LUBAC but less efficiently than HOIL-1L C460 (<xref ref-type="fig" rid="fig7">Figure 7E</xref>).</p><p>These data collectively show that HOIP assembles linear ubiquitin chains, which are subsequently branched by HOIL-1L in a process involving its NZF domain and which requires the catalytic activity of HOIP.</p><p>In summary, we identified that LUBAC assembles heterotypic linear/ester-linked poly-ubiquitin chains in vitro and in cells in response to TNF stimulation. We also show that these chains are synthesized through the concerted action of HOIP and HOIL-1L (<xref ref-type="fig" rid="fig8">Figure 8</xref>). These chains may contribute in modulating the speed and/or efficiency of linear ubiquitin chain synthesis by LUBAC.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Proposed model for concerted action between HOIL-1-interacting protein (HOIP) and heme-oxidized IRP2 ubiquitin ligase 1 (HOIL-1L) in heterotypic chain assembly.</title><p>HOIP and HOIL-1L assemble heterotypic chains through a Cys relay mechanism. HOIP forms a thioester bond to ubiquitin, which can be either transferred to a thioester bond on HOIL-1L or added to a nascent linear ubiquitin chain. HOIL-1L subsequently binds the linear ubiquitin chain through its Npl zinc finger (NZF) domain and branches it with ester linkages. The resulting heterotypic poly-ubiquitin chains contain predominantly linear linkages with ester-linked branches.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-fig8-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We present here the first 3D reconstruction of the ternary LUBAC. We cannot determine the exact positions of HOIP, HOIL-1L, and SHARPIN in the map at the current resolution; however, our map is the first structure encompassing the LUBAC holoenzyme. We also made other novel structural observations that LUBAC exists as monomers and dimers of a ternary complex with 1:1:1 stoichiometry between HOIP, HOIL-1L, and SHARPIN. This is in agreement with observations made in recent structural work (<xref ref-type="bibr" rid="bib22">Fujita et al., 2018</xref>). We also present new data addressing the question of LUBAC oligomerization. Early gel filtration analysis of cell-derived LUBAC suggested formation of a large or oligomeric complex with a molecular mass of over 600 kDa (<xref ref-type="bibr" rid="bib33">Kirisako et al., 2006</xref>). However, our MP measurements using recombinant LUBAC show that this is not the case in vitro. This could be due to LUBAC in cells interacting with cellular components such as SPATA2 and CYLD (<xref ref-type="bibr" rid="bib74">Wagner et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Schlicher et al., 2016</xref>; <xref ref-type="bibr" rid="bib35">Kupka et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Elliott et al., 2016</xref>). This discrepancy would also be accounted for by a particle of non-globular structure, which would elute earlier than expected from a gel filtration column (<xref ref-type="bibr" rid="bib59">Siegel and Monty, 1966</xref>; <xref ref-type="bibr" rid="bib15">Erickson, 2009</xref>). Accordingly, the 3D map we obtained from negative stain electron micrographs shows a particle of elongated structure.</p><p>We propose a catalytic Cys relay mechanism in LUBAC: HOIP receives ubiquitin from the E2 and uses this ubiquitin to assemble linear chains or transfers it to HOIL-1L, which then branches the chains assisted by its NZF domain (<xref ref-type="fig" rid="fig8">Figure 8</xref>). One recent example of such a mechanism is the E3 ligase MYCBP2, which also conjugates the ubiquitin to Thr residues through an ester bond (<xref ref-type="bibr" rid="bib46">Pao et al., 2018</xref>). A relay mechanism would require spatial proximity between the catalytic sites of the two ligases. Our XL-MS data show that this is indeed the case based on cross-linking between the RBR domains of HOIP and HOIL-1L. We also detected proximity between the HOIL-1L NZF and the RBR domains of both HOIP and HOIL-1L, which could contribute to the branching of the linearly linked ubiquitin dimer. Collectively, these observations suggest that LUBAC has a single catalytic centre containing the RBR domains of HOIP and HOIL-1L.</p><p>HOIP and HOIL-1L have distinct catalytic behaviour. HOIP exclusively targets Met1 of a ubiquitin moiety for polymerization (<xref ref-type="bibr" rid="bib65">Swatek et al., 2019</xref>); in contrast, HOIL-1L seems to have more flexibility with target sites in forming ester bonds. We identified Thr12 and Thr55 in ubiquitin as target sites by mass spectrometry; yet individual and concomitant mutation of these residues did not abolish heterotypic chain assembly suggesting existence of secondary sites. Indeed, in ubiquitin, Thr12 is structurally located in the vicinity of Thr7, Thr9, and Thr14, whereas Thr55 is located near Thr22, Ser20, and Ser57. A recent study identified Thr12, Ser20, and Thr22, but not Thr55, as target sites by isolated HOIL-1L (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>). These differences may depend on HOIL-1L as an isolated protein, or HOIL-1L as a part of LUBAC where HOIP and SHARPIN contribute to site selection.</p><p>We speculate that HOIP and SHARPIN contribute to the catalytic action of HOIL-1L based on the observed loss of the HOIL-1L auto-ubiquitination signal in cells derived from SHARPIN-deficient mice (<xref ref-type="bibr" rid="bib24">Gerlach et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Ikeda et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Tokunaga et al., 2011</xref>) and HOIP knockout mice (<xref ref-type="bibr" rid="bib47">Peltzer et al., 2014</xref>). This effect is identical in cells derived from HOIL-1L C458S mice (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>), as well as HOIL-1L C458A mice from this study. Investigating the precise mechanism how the non-catalytic LUBAC component SHARPIN contributes to the HOIL-1L catalytic activity may shed light on its role in the complex.</p><p>Our analysis of chain branching on substrate-conjugated ubiquitin chains suggests that the oxyester branch points of the chain are located distally from the substrate. Treatment of NEMO in vitro ubiquitination reactions resulted in some change of signal, but the overall levels of ubiquitinated substrate were unperturbed, indicating that linear ubiquitin chains are not conjugated onto NEMO via oxyester bonds. This is consistent with a previous report showing that loss of HOIL-1L catalytic activity impairs but does not prevent conjugation of linear ubiquitin chains to the LUBAC substrates IRAK1, IRAK2, and MyD88 (<xref ref-type="bibr" rid="bib32">Kelsall et al., 2019</xref>). Our results would also suggest that HOIL-1L is not responsible for priming substrates with a mono-ubiquitin that is then extended into an linear ubiquitin chain by HOIP. However, based on our data, we cannot exclude the possibility that HOIL-1L also has Lys-directed ubiquitin conjugation capabilities as has been suggested by prior studies (<xref ref-type="bibr" rid="bib61">Smit et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Fuseya et al., 2020</xref>).</p><p>Our data suggests that linear ubiquitin chains are heavily branched in cells. Hydroxylamine treatment results in a near complete loss of signal from linear ubiquitin chains in cells, which suggests that linear chains are heavily branched. In contrast, our in vitro data suggests that only small populations of linear chains are successfully branched. One explanation could be that there are other factors present in cells that assist HOIL-1L in the process of chain branching and which remain hitherto unidentified.</p><p>DUBs targeting ester linkages remain to be identified. Our data show that a fragment of Cezanne, a DUB specific for Lys11 linkages (<xref ref-type="bibr" rid="bib3">Bremm et al., 2010</xref>; <xref ref-type="bibr" rid="bib43">Mevissen et al., 2016</xref>), can cleave the ester-linked branches in vitro. Cezanne is a known negative regulator of NF-κB (<xref ref-type="bibr" rid="bib14">Enesa et al., 2008</xref>; <xref ref-type="bibr" rid="bib17">Evans et al., 2003</xref>; <xref ref-type="bibr" rid="bib16">Evans et al., 2001</xref>; <xref ref-type="bibr" rid="bib39">Luong et al., 2013</xref>). It is therefore tempting to speculate that it has esterase activity and targets the LUBAC-assembled chains during its counteraction of NF-κB activation. However, further work will be necessary to identify potential esterase activity in DUBs including Cezanne.</p><p>Understanding the biological functions of the heterotypic chains is a very important aspect. A recent study using HOIL-1L ΔRBR mice and HOIL-1L knock-in cell of ligase inactive mutant showed that HOIL-1L ligase activity regulates TNF-induced signalling and apoptosis (<xref ref-type="bibr" rid="bib23">Fuseya et al., 2020</xref>). In line with their observations, we also observed that HOIL-1L Cys458 mutant as a part of LUBAC increased the linear ubiquitination signal in comparison to the WT control. They also showed that RIPK1, a known substrate of LUBAC, in the TNF complex is linearly ubiquitinated in at increased levels. These data indicate that the HOIL-1L catalytic activity negatively regulates ubiquitination of the substrates in cells, which also supports our observations in vitro. In cells, they could not detect oxyester linkage on HOIL-1L but on HOIP in WT cells, which is abolished in HOIL-1L catalytic inactive cells. Since they detect remaining HOIL-1L mono-ubiquitination signal even when all the Lys residues in HOIL-1L are mutated to Arg, it is probable that there are heterogeneous population of ubiquitination sites in HOIL-1L. Furthermore, this could be due to that oxyester bond being biochemically less stable and being a minor fraction in cells. Since HOIL-1L inactive mutant is no longer ubiquitinated in vitro, upregulated ubiquitination of HOIL-1L mutant in cells (<xref ref-type="bibr" rid="bib23">Fuseya et al., 2020</xref>) may depend on interacting partners existing in cells.</p><p>To further understand the roles of these ester-linked branches in biology, it will be important to dissect biochemical characteristics such as their interaction mode with known linear ubiquitin chain-specific binding domains (<xref ref-type="bibr" rid="bib18">Fennell et al., 2018</xref>), existence of DUBs, and other possible ligases that catalyse their formation in future studies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Plasmids</title><p>pGEX-6p1-<italic>Hs</italic>OTULIN, pGEX-6p1-<italic>Hs</italic>HOIP, pGEX-6p1-<italic>Hs</italic>HOIL-1L, and pGEX-6p1-<italic>Hs</italic>SHARPIN (<xref ref-type="bibr" rid="bib19">Fennell et al., 2019</xref>), as well as pGEX-4t1-mNEMO<sub>250-412</sub> <xref ref-type="bibr" rid="bib73">Wagner et al., 2008</xref> have been previously reported. pGEX-6p1-<italic>Hs</italic>UbcH7 was kindly provided by Katrin Rittinger (Francis Crick Institute, UK). pOPIN-K-<italic>Hs</italic>OTUD1<sub>287-481</sub> (<xref ref-type="bibr" rid="bib42">Mevissen et al., 2013</xref>), pOPIN-K-<italic>Hs</italic>OTUD2 (<xref ref-type="bibr" rid="bib42">Mevissen et al., 2013</xref>), pOPIN-K-<italic>Hs</italic>OTUD3<sub>52-209</sub> (<xref ref-type="bibr" rid="bib42">Mevissen et al., 2013</xref>), pOPIN-K-<italic>Hs</italic>Cezanne<sub>53-446</sub> (<xref ref-type="bibr" rid="bib73">Wagner et al., 2008</xref>), pOPIN-K-<italic>Hs</italic>TRABID<sub>245-697</sub> (<xref ref-type="bibr" rid="bib37">Licchesi et al., 2011</xref>), pOPIN-K-<italic>Hs</italic>OTUB1 (<xref ref-type="bibr" rid="bib42">Mevissen et al., 2013</xref>), pOPIN-K-vOTU<sub>1-183</sub> (<xref ref-type="bibr" rid="bib1">Akutsu et al., 2011</xref>), and pOPIN-S-<italic>Hs</italic>Usp21<sub>196-565</sub> (<xref ref-type="bibr" rid="bib78">Ye et al., 2011</xref>) were kind gifts from David Komander. ORF of ubiquitin T<sub>12</sub>V, T<sub>55</sub>V, and T<sub>12/55</sub>V mutants were generated by PCR and inserted twice into a pETDuet-1 vector by isothermal assembly. pKL-der-<italic>Hs</italic>LUBAC was assembled by inserting <italic>Hs</italic>HOIP, His<sub>6</sub>-<italic>Hs</italic>HOIL-1L, and Strep(II)-<italic>Hs</italic>Sharpin coding sequences into a pKL-derived vector using BsaI. pKL-der-<italic>Hs</italic>LUBAC-HOIP(C<sub>885</sub>A), pKL-der-<italic>Hs</italic>LUBAC-HOIL-1L(C<sub>460</sub>A), pKL-der-<italic>Hs</italic>LUBAC-HOIP(C<sub>885</sub>A)-HOIL-1L(C<sub>460</sub>A), and pKL-der-<italic>Hs</italic>LUBAC-HOIL-1L(T<sub>203</sub>A/R<sub>210</sub>A) were generated by a standard protocol of site-directed mutagenesis.</p></sec><sec id="s4-2"><title>Antibodies</title><p>The following antibodies were used in this study: anti-HOIL-1L (clone 2E2; Merck MABC576), anti-HOIP (Merck SAB2102031), anti-IκBα (44D4; Cell Signaling Technology 4812), anti-Ser32/36-phospho-IκBα (5A5; Cell Signaling Technology 9246), anti-SHARPIN (NOVUS Biologicals NBP2-04116), anti-ubiquitin (P4D1; Santa Cruz Biotechnology sc-8017), anti-vinculin (Merck V9131). All antibodies were diluted in TBS 5% (w/v) BSA, 0.05% (v/v) Triton according to the manufacturer’s recommended dilutions.</p></sec><sec id="s4-3"><title>Generation of anti-linear ubiquitin monoclonal antibody</title><p>Mouse monoclonal anti-linear ubiquitin chain antibody (clone LUB4) was generated by immunizing 5-week-old male ICR mice (Charles River Laboratory, Yokohama, Japan) with a neoepitope peptide (LRLRGGMQIFVK) derived from the linear ubiquitin chain, which comprises a ubiquitin C-terminal sequence (amino acids 71–76) and a ubiquitin N-terminal sequence (amino acids 1–6) conjugated to ovalbumin. Cells isolated from the popliteal and inguinal lymph nodes were fused with a mouse myeloma cell line, PAI. Supernatants of the growing hybridomas were tested by direct enzyme-linked immunosorbent assay and western blot analysis. Specificity of the antibody clone was validated by immunoblotting (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p></sec><sec id="s4-4"><title>Immunoblotting</title><p>Protein samples were mixed with SDS -sample buffer containing 5% β-mercaptoethanol and denatured at 96°C for 5 min. Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes (GE Healthcare 10600019 or 10600001). Appropriate transfer of proteins was verified by staining of membranes with the Ponceau S solution (Roth 5938.1). Membranes were blocked with TBS 5% BSA (w/v), 0.05% Triton (v/v), and blotted at 4°C overnight with indicated primary antibodies. Membranes were subsequently blotted with anti-mouse-IgG-HRP conjugate (Bio-Rad 1706516) or anti-rabbit-HRP conjugate (Agilent Dako P044801-2) and visualized with Western Blotting Luminol Reagent (Santa Cruz Biotechnology sc-2048) using Amersham Hyperfilm MP (GE Healthcare) chemiluminescence films.</p></sec><sec id="s4-5"><title>Purification of recombinant LUBAC from insect cells</title><p>The transfer vector carrying the HsHOIP, His6-HsHOIL-1L, and Strep(II)-HsSHARPIN coding sequences was cloned using the GoldenBac cloning system (<xref ref-type="bibr" rid="bib44">Neuhold et al., 2020</xref>) and transposed into the bacmid backbone carried by DH10EmBacY cells (Geneva Biotech). The bacmid was then used to generate a V0 virus stock in Sf9 cells, which was amplified once to give a V1 virus stock used to infect 1 l cultures of Sf9 cells (Expression Systems). Cells were grown in ESF 921 Insect Cell Culture Medium Protein Free (Expression Systems 96-001-01) at 27°C and infected at a density of 2 × 10<sup>6</sup> cells/ml. Cells were harvested 72 hr after growth arrest and resuspended in 100 mM HEPES, 100 mM NaCl, 100 mM KCl, 100 mM Arg, 10 mM MgSO<sub>4</sub>, 20 mM imidazole, pH 8.0 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail (Merk). Cells were lysed by four passes through a Constant Systems Cell Disruptor at 1.4 kBar and then supplemented with 100 mM Benzonase and 10 mM PMSF. Lysates were cleared by centrifugation at 48,284 g for 45 min at 4°C and loaded into a HisTrap FF cartridge (GE Healthcare). Proteins were eluted with 100 mM HEPES, 100 mM NaCl, 100 mM KCl, 50 mM arginine, 500 mM imidazole, pH 8.0 and loaded into a Streptactin Superflow cartridge (IBA Lifesciences 2-1238-001). Cartridge was washed with 100 mM HEPES, 100 mM NaCl, 100 mM KCl, pH 8.0, and proteins were eluted with 100 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM D-desthiobiotin, pH 8.0. Complexes were concentrated using a Centriprep (Merck 4311) centrifugal filter with a 50 kDa cut-off, then flash-frozen in liquid nitrogen and stored at −80°C.</p></sec><sec id="s4-6"><title>Protein purification from <italic>E. coli</italic></title><p>Proteins were expressed in <italic>E. coli</italic> BL21(DE3) cells (Agilent) for 16 hr at 18°C, 25°C, or 30°C. Cell pellets were harvested and lysed by sonication with a Branson 450 Digital Sonifier (Branson) by pulsing for 1.5 min with 1 s pulses and 2 s pauses at amplitude of 60%. Cells expressing GST-NEMO-Strep(II), GST-HOIP, GST-HOIL-1L, GST-SHARPIN, or GST-UbcH7 were lysed in 100 mM HEPES, 500 mM NaCl, pH 7.5 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail. Cells expressing ubiquitin mutants were lysed in 50 mM ammonium acetate, pH 4.5 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail. Cells expressing His<sub>6</sub>-SUMO-Usp21<sub>196-565</sub> were lysed in 50 mM Tris, 200 mM NaCl, pH 8.5 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail. Cells expressing GST-OTUD1<sub>287-481</sub>, GST-OTUD2, GST-OTUD3<sub>52-209</sub>, GST-Cezanne<sub>53-446</sub>, GST-TRABID<sub>245-697</sub>, GST-OTUB1, GST-OTULIN, and GST-vOTU<sub>1-183</sub> were lysed in 50 mM Tris 200 mM NaCl, 5 mM DTT, pH 8.5 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail. Cell lysates were supplemented with 500 U Recombinant DNAse (Merck 4716728001) and 100 mM PMSF. For purification of HOIP, HOIL-1L, SHARPIN, NEMO-Strep(II), and UbcH7 lysates were loaded into a GSTrap HP cartridge (GE Healthcare); once loaded GST-PreScission Protease (GE Healthcare) was injected into the column and incubated overnight at 4°C. UbcH7, HOIP, HOIL-1L, and SHARPIN were eluted and further purified over a Superdex 75 16/600 pd or a Superdex 200 16/600 pd column (GE Healthcare) equilibrated in 50 mM HEPES, 150 mM NaCl, pH 7.5. NEMO-Strep(II) was loaded into a Streptactin Superflow cartridge (IBA Lifesciences) and eluted in 50 mM Tris, 150 mM NaCl, 1 mM DTT, 1.5 mM D-desthiobiotin, pH 7.5. For ubiquitin purification, lysates were loaded into a ResourceS (GE Healthcare) cartridge and eluted in a gradient of 0–500 mM NaCl in 50 mM ammonium acetate, pH 4.5. The protein was further purified over a Superdex 75 16/600 pd column (GE Healthcare) equilibrated in 50 mM HEPES, 150 mM NaCl, pH 7.5. OTUD1<sub>287-481</sub>, OTUD2, OTUD3<sub>52-209</sub>, Cezanne<sub>53-446</sub>, TRABID<sub>245-697</sub>, OTUB1, OTULIN, and vOTU<sub>1-183</sub> were purified as described in <xref ref-type="bibr" rid="bib27">Hospenthal et al., 2015</xref>, in brief: lysates were loaded into a GSTrap HP cartridge (GE Healthcare) and treated overnight with GST-PreScission Protease (GE Healthcare). Eluted proteins were further purified over a Superdex 75 16/600 pd column (GE Healthcare) equilibrated in 50 mM Tris, 200 mM NaCl, 5 mM DTT, pH 8.5. For purification of Usp21<sub>196-565</sub>, lysate was loaded ino a HisTrap FF cartridge (GE Healthcare) and eluted with 50 mM Tris, 200 mM NaCl, 500 mM imidazole, pH 8.5. Imidazole was removed by buffer exchange using a Vivaspin centrifugal filter (Sartorius) with a 10 kDa cut-off, eluate was treated with SENP2 (R&amp;D Systems E-710–050) overnight, and protein was further purified over a Superdex 75 16/600 pd column (GE Healthcare) equilibrated in 50 mM Tris, 200 mM NaCl, 5 mM DTT, pH 8.5. Proteins were concentrated using Vivaspin centrifugal filters (Sartorius) of appropriate cut-offs, flash-frozen in liquid nitrogen and stored at −80°C. For GST and GST-NEMO<sub>250-412</sub>, they were expressed in BL21 (DE3) cells for 16 hr at 25°C (<xref ref-type="bibr" rid="bib73">Wagner et al., 2008</xref>). Cells were harvested and lysed by sonication in 50 mM Tris, 100 mM EDTA, 50 mM EGTA, 150 mM NaCl, pH 7.5 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail, lysates were incubated overnight at 4°C with 400 µl of Glutathione Sepharose 4B per l of expression culture (GE Healthcare GE17-0756-01) with gentle rotation. Beads immobilized samples were washed in 50 mM Tris, 100 mM EDTA, 150 mM NaCl, 0.5% Triton, pH 7.5 and resuspended in 50 mM Tris, pH 7.5 (<xref ref-type="bibr" rid="bib10">Einarson et al., 2007</xref>).</p></sec><sec id="s4-7"><title>MP measurement of LUBAC reconstitution</title><p>For MP measurements, microscope coverslips (No. 1.5, 24 × 50, VMR) were cleaned by sequential sonication in Milli-Q/isopropanol/Milli Q for 5 min at each step, followed by drying with a clean nitrogen stream. Silicon gasket (3 mm diameter, Grace Bio-labs) to create chambers were also washed with Milli-Q/isopropanol/Milli Q and dried using clean nitrogen stream.</p><p>To reconstitute LUBAC from individually purified proteins, namely SHARPIN, HOIP, and HOIL, three proteins were mixed at 400 pmol, each protein was mixed for a 100 μl reaction mixture, and incubated for 10 min at room temperature (RT). Subsequently, the mixture was diluted 100-fold and then repeats were collected for 1 min each, using Refeyn OneMP like set up at the lab of Philipp Kukura. The data was analysed using DiscoverMP software (Refeyn Ltd, Oxford, UK) as described elsewhere. Briefly, six frames were averaged to generate ratiometric frames for analysis and threshold 1 at 0.5 and threshold 2 at 0.25 were used to analyse the ratiometric movie. Contrast of the analysed data was converted to mass using the mass to contrast relation for an in-house mass standard containing protein species at 90, 180, 360, and 540 kDa. Compilation of the mass of the individual repeats and histogram generation was done using in-house python script.</p></sec><sec id="s4-8"><title>GST pull-down assays and NH<sub>2</sub>OH treatment</title><p>MEFs were lysed in lysis buffer containing 50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 25 mM NAF, 10 μM ZnCl<sub>2</sub>, 10 mM NEM, 1 mM PMSF, 5 mM Na<sub>3</sub>VO<sub>4</sub>, pH 7.4 supplemented with 1 tablet of cOmplete Mini EDTA-free protease inhibitor cocktail. Lysates were cleared by centrifugation at 21,130 <italic>g</italic> for 15 min at 4°C. Equal amounts of GST or GST-NEMO<sub>250-412</sub>, as determined by SDS-PAGE, were added to lysates and samples were incubated overnight at 4°C with gentle rocking. Beads washed with PBS, then buffer containing 100 mM HEPES, 100 mM NaCl, 100 mM KCl, pH 8.0, then resuspended in a buffer containing 100 mM HEPES, 100 mM NaCl, 100 mM KCl, pH 9.0 ± 1.2 M NH<sub>2</sub>OH. Reactions were incubated 30 min at 37°C in a Thermomixer comfort (Eppendorf, Germany) thermomixer; reactions were stopped with SDS buffer and incubated at 37°C, then subjected to SDS-PAGE and immunoblotting with the indicated antibodies.</p></sec><sec id="s4-9"><title>Negative staining</title><p>Recombinant LUBAC was run through a Superdex S200 Increase 3.2/300 column equilibrated in 100 mM HEPES, 100 mM NaCl, 100 mM KCl, pH 8.0. Fractions containing the peaks for recombinant LUBAC were collected for staining on 400-mesh Cu/Pd grids (Agar Scientific G2440PF) coated with a 3-nm-thick continuous carbon support film. For staining grids were glow discharged for 1 min at 200 mA and 10<sup>−1</sup> mBar in a BAL-TEC SCD005 sputter coater (BAL-TEC, Liechtenstein), samples were pipetted onto the grid and incubated for 1 min before blotting. Grids were then stained with 2% (w/v) uranyl acetate, pH 4 (Merck) for 1 min, blotted dry, and left to air-dry for 10 min at RT and pressure before being stored in a desiccator.</p></sec><sec id="s4-10"><title>Electron microscopy</title><p>Grids were screened on a FEI Morgani 268D transmission electron microscope (Thermo Fisher Scientific, Amsterdam, The Netherlands) operated at 80 kV using a 300 µm condenser lens aperture and 50 µm objective lens aperture; images were recorded on an 11 megapixel Morada CCD camera (Olympus-SIS, Germany). For data acquisition grids were imaged on a FEI Tecnai G2 20 (Thermo Fisher Scientific, Amsterdam, The Netherlands) operated at 200 kV using a 200 µm condenser lens aperture and 100 µm objective lens aperture; imaged on a FEI Eagle 4 k HS CCD camera (Thermo Fisher Scientific, Amsterdam, The Netherlands) with a pixel size of 1.85 Å/pixel.</p></sec><sec id="s4-11"><title>Image processing of negative stain data</title><p>The negative stain data was processed in relion 3.1 (<xref ref-type="bibr" rid="bib80">Zivanov et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Scheres, 2012a</xref>; <xref ref-type="bibr" rid="bib56">Scheres, 2012b</xref>) unless otherwise stated. CTF parameters were determined using CTFFIND4 (<xref ref-type="bibr" rid="bib53">Rohou and Grigorieff, 2015</xref>). Micrographs that suffered from drift were excluded from the further analysis; 600 particles were picked manually and classified in 2D to yield templates for autopicking. Autopicking yielded 637,000 particles that were extracted in a box of 180 pixels but cropped in Fourier space to 90 pixels. The dataset was split in six subsets that were subjected to 2D classification. Class averages showing distinct particle features were kept and their particles were combined for a final round of 2D classification yielding 163,000 remaining particles. These particles were subjected to initial model generation yielding three models that are very similar in shape. The most isotropic model was used for 3D classification once again yielding similar models. All steps were performed without CTF correction to avoid artifacts and over-fitting. Back-projections of the final map were generated to validate the self-consistency of the model.</p></sec><sec id="s4-12"><title>Cross-linking mass spectrometry</title><p>For cross-linking preparations, 100 µg of recombinant LUBAC were cross-linked in 100 mM HEPES, 100 mM NaCl, 100 mM KCl, pH 8.0 with 3.75 mM DMTMM (Merck 74104) for 1 hr at RT. The reaction cross-linker was removed using a Zeba Micro Spin desalting column (Thermo Fisher Scientific 89883). Samples were dried at 45°C in a vacuum centrifuge connected to a cooling trap (Heto Lab Equipment) and then resuspended in 8 M urea. Proteins were subjected to reduction with 2.5 mM TCEP and subsequently alkylated with 5 mM iodoacetamide for 30 min at RT after which samples were diluted 1:7 (v/v) with 50 mM ammonium bicarbonate (ABC). Samples were digested with 2 µg Trypsin (Promega V5280) for 20 hr at 37°C, samples were then digested for a further 3 hr with 2 µg Chymotrypsin (Roche 11418467001) at 25°C. Digest was quenched with 0.4% (v/v) trifluoroacetic acid (TFA) and samples were loaded on a Sep-Pak C18 cartridge (Waters WAT054955) equilibrated with 5% (v/v) acetonitrile, 0.1% (v/v) formic acid (FA); samples were eluted with 50% (v/v) acetonitrile, 0.1% (v/v) FA. Cross-linked peptides were enriched in a Superdex 30 Increase 3.2/300 column (GE Healthcare) equilibrated with 30% (v/v) acetonitrile, 0.1% (v/v) TFA. Fractions containing cross-linked peptides were evaporated to dryness and resuspended in 5% (v/v) acetonitrile, 0.1% (v/v) TFA. Cross-linked peptides were separated on an UltiMate 3000 RSLC nano HPLC system (Thermo Fisher Scientific) coupled to an Orbitrap Fusion Lumos Tribid mass spectrometer (Thermo Fisher Scientific) equipped with a Proxeon nanospray source (Thermo Fisher Scientific). Peptides were loaded onto an Acclaim PepMap 100 C18 HPLC column (Thermo Fisher Scientific 160454) in a 0.1% TFA mobile phase. Peptides were eluted into an Acclaim PepMap 100 C18 HPLC column (Thermo Fisher Scientific 164739) in a binary gradient between mobile phase A (99.9/0.1% v/v water/FA) and mobile phase B (19.92/80/0.08% v/v/v water/acetonitrile/FA). The gradient was run from 2% to 45% mobile phase B over 3 hr and then increased to 90% B over 5 min.</p><p>Measurement was performed in data-dependent mode with 3 s cycle time at a resolution of 60,000 in the m/z range of 350–1500. Precursor ions with a charge state of +3 to +7 were fragmented by HCD with collision energy of 29% and fragments were recorded with a resolution of 45,000 and precursor isolation width of 1.0 m/z. A dynamic exclusion time of 30 s was used. Fragment spectra peak lists were generated with MSConvert v3.0.9974 (<xref ref-type="bibr" rid="bib5">Chambers et al., 2012</xref>) with a peak-picking filter. Cross-link identification was done using XiSearch v1.6.742 (<xref ref-type="bibr" rid="bib25">Giese et al., 2016</xref>) with 6 ppm MS<sup>1</sup>-accuracy, 20 ppm MS<sup>2</sup>-accuracy, DMTMM cross-linking was set with asymmetric reaction specificity for lysine and arginine to glutamate and aspartate; carbamidomethylation of cysteine was a fixed modification, oxidation of methionine was a variable modification, trypsin/chymotrypsin digest was set with up to four missed cleavages, and all other variables were left at default settings. Identified cross-links were filtered to 10% FDR at the link level with XiFDR v1.1.27 (<xref ref-type="bibr" rid="bib21">Fischer and Rappsilber, 2017</xref>), links with FDR &lt; 5% were visualized with xVis (<xref ref-type="bibr" rid="bib26">Grimm et al., 2015</xref>).</p></sec><sec id="s4-13"><title>In vitro ubiquitination assay</title><p>Reaction mixtures were prepared containing Ube1, UbcH7, and either LUBAC or HOIP, HOIL-1L, and SHARPIN with all proteins at 0.338 µM final concentration in a buffer containing 50 mM HEPES, 150 mM NaCl, 0.5 mM MgSO<sub>4</sub>, pH 8.0 (described in <xref ref-type="bibr" rid="bib28">Ikeda et al., 2011</xref>). Reactions were started by addition of 59.0 µM ubiquitin or fluorescein-tagged ubiquitin, 2 mM ATP, and 0.5 µg of NEMO where indicated, then incubated at 37°C in a Mastercycler nexus (Eppendorf, Germany) thermocycler for 2 hr unless otherwise stated. Reaction was stopped by addition of SDS buffer and boiling at 95°C, proteins were resolved by SDS-PAGE, and analysed by immunoblotting with the indicated antibodies or by fluorescence imaging. Recombinant human ubiquitin, His<sub>6</sub>-ubiquitin, and ubiquitin KR mutants (K<sub>6</sub>R, K<sub>11</sub>R, K<sub>27</sub>R, K<sub>29</sub>R, K<sub>33</sub>R, K<sub>48</sub>R, K<sub>63</sub>R, K<sub>0</sub>) were purchased from Boston Biochem.</p></sec><sec id="s4-14"><title>NH<sub>2</sub>OH treatment of in vitro assembled poly-ubiquitin chains</title><p>LUBAC in vitro and UbiCRest reactions were mixed with 1.2 M NH<sub>2</sub>OH in 40 mM HEPES, 40 mM NaCl, 40 mM KCl, pH 9.0, and reactions were incubated at 37°C in a Thermomixer comfort (Eppendorf, Germany) thermomixer for 2 hr. Reactions were stopped by addition of SDS buffer and incubated at 37°C, then subjected to SDS-PAGE and immunoblotting with the indicated antibodies.</p></sec><sec id="s4-15"><title>UbiCRest assay</title><p>Protocol was adapted from <xref ref-type="bibr" rid="bib27">Hospenthal et al., 2015</xref>; in brief, DUBs were diluted to 0.8 µM (OTUD1<sub>287-481</sub>, OTUD2, OTUD3<sub>52-209</sub>, Cezanne<sub>53-446</sub>, TRABID<sub>245-697</sub>, OTUB1, and OTULIN) or 10 µM (vOTU<sub>1-183</sub>, Usp21<sub>196-565</sub>) in 25 mM Tris, 150 mM NaCl, 10 mM DTT, pH 7.5, and incubated at RT for 10 min. One LUBAC in vitro chain assembly reaction was divided into aliquots and mixed at a 1:1 (v/v) ratio with each DUB in 50 mM Tris, 50 mM NaCl, 5 mM DTT, pH 7.5, and reactions were incubated at 37°C in a Thermomixer comfort (Eppendorf, Germany) thermomixer for 2 hr. Reactions were stopped as described above and analysed by immunoblotting with the indicated antibodies.</p></sec><sec id="s4-16"><title>Mass spectrometry</title><p>LUBAC in vitro chain assembly reactions were resolved on 4–15% Mini-PROTEAN TGX gels (Bio-Rad 4561083) and stained with Instant Blue (Merck ISB1L). Fragments were excised from the gel and slices were washed sequentially with 100 mM ABC, then 50% (v/v) acetonitrile 50 mM ABC at 57°C for 30 min. Gel slices were shrunk in 100% acetonitrile and reduced with 1 mg/ml DTT in 100 mM ABC. Slices were then alkylated with MMTS in 100 mM ABC at RT for 30 min. Gel slices were subjected to tryptic digest (Promega V5280) overnight at 37°C. Peptides were extracted from gel slices by sonication in 5% (v/v) FA. Peptides were loaded into a PepMap C18 (5 mm × 300 μm ID, 5 μm particles, 100 Å pore size; Thermo Fisher Scientific) trap column on an UltiMate 3000 RSLC nano HPLC system (Thermo Fisher Scientific, Amsterdam, The Netherlands) coupled to a Q Exactive HF-X mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a Proxeon nanospray source (Thermo Fisher Scientific, Odense, Denmark) using a solution of 0.1% (v/v) TFA as the mobile phase. Samples were loaded at a flow rate of 25 µl/min for 10 min and then eluted into an analytical C18 (500 mm × 75 μm ID, 2 μm, 100 Å; Thermo Fisher Scientific, Amsterdam, The Netherlands) column in a binary gradient between mobile phase A (99.9/0.1% v/v water/FA) and mobile phase B (19.92/80/0.08% v/v/v water/acetonitrile/FA). The gradient was run from 98%/2% A/B to 35%/65% A/B over 1 hr; the gradient was then adjusted to 5%/95% A/B over 5 min and held for a further 5 min before returning to 98%/2% A/B. The Q Exactive HF-X mass spectrometer was operated in data-dependent mode, using a full scan (m/z range 380–1500, nominal resolution of 60,000, target value 1<sub>E</sub>; <xref ref-type="bibr" rid="bib75">Wang et al., 2007</xref>) followed by MS/MS scans of the 10 most abundant ions. MS/MS spectra were acquired using normalized collision energy of 28, isolation width of 1.0 m/z, resolution of 30,000, and target value was set to 1<sub>E</sub> (<xref ref-type="bibr" rid="bib72">Vosper et al., 2009</xref>). Precursor ions selected for fragmentation were put on a dynamic exclusion list for 20 s (excluding charge states 1, 7, 8, &gt;8). The minimum AGC target was set to 5<sub>E</sub> (<xref ref-type="bibr" rid="bib40">McClellan et al., 2019</xref>) and intensity threshold was calculated to be 4.8<sub>E</sub> (<xref ref-type="bibr" rid="bib41">McDowell and Philpott, 2013</xref>); the peptide match feature was set to preferred and the exclude isotopes feature was enabled. For peptide identification, the generated .raw files were loaded into Proteome Discoverer (version 2.3.0.523, Thermo Fisher Scientific). All hereby created MS/MS spectra were searched using MSAmanda v2.0.0. 12368 (<xref ref-type="bibr" rid="bib9">Dorfer et al., 2014</xref>). The .raw files were searched against the <italic>Spodoptera frugiperda</italic> database (23,492 sequences; 12,713,298 residues) and the swissprot-ecoli database (4418 sequences; 1,386,900 residues) to generate a .fasta file; search parameters used were peptide mass tolerance ± 5 ppm, fragment mass tolerance 15 ppm, maximum of two missed cleavages; the result was filtered to 1% FDR on protein level using Percolator algorithm integrated in Thermo Proteome Discoverer. The sub-database was generated for further processing. The .raw files were then searched using the generated .fasta file using the following search parameters: β-methylthiolation on cysteine was set as a fixed modification; oxidation of methionine, deamidation of asparagine and glutamine, acetylation of lysine, phosphorylation of serine, threonine and tyrosine; methylation of lysine and arginine, di-methylation of lysine and arginine, tri-methylation of lysine, biotinylation of lysine, carbamylation of lysine, ubiquitination of lysine, serine, threonine, and tyrosine were set as variable modifications. Monoisotopic masses were searched within unrestricted protein masses for tryptic enzymatic specificity. The peptide mass tolerance was set to ±5 ppm, fragment mass tolerance to ±15 ppm, maximum number of missed cleavages was set to 2, results were filtered to 1% FDR on protein level using Percolator algorithm (<xref ref-type="bibr" rid="bib31">Käll et al., 2007</xref>) as integrated in Proteome Discoverer. The localization of the posttranslational modification sites within the peptides was performed with the tool ptmRS, based on the tool phosphoRS (<xref ref-type="bibr" rid="bib67">Taus et al., 2011</xref>). Peptide areas were quantified using in-house-developed tool apQuant (<xref ref-type="bibr" rid="bib8">Doblmann et al., 2019</xref>).</p></sec><sec id="s4-17"><title>Generation of C57BL/6J <italic>Rbck1</italic><sup>C458A/C458A</sup> mice and genotyping</title><p>C57BL/6J <italic>Rbck1<sup>C458A/C458A</sup></italic> mice were generated as described elsewhere (<xref ref-type="bibr" rid="bib19">Fennell et al., 2019</xref>). The gRNA targeting sequence was designed using the online tool ChopChop (<ext-link ext-link-type="uri" xlink:href="http://chopchop.cbu.uib.no">http://chopchop.cbu.uib.no</ext-link>), two separate gRNA sequences were selected (gRNA1 and gRNA63). The gRNA sequences were inserted to pX330-U6-Chimeric_BB-CBh-hSpCas9 (a gift from Feng Zhang, Addgene plasmid #42230) (<xref ref-type="bibr" rid="bib6">Cong et al., 2013</xref>) as annealed oligonucleotides (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>) using BbsI. A T7-gRNA product was amplified by PCR and used for in vitro transcription using the MEGAshortscript T7 kit (Invitrogen AM1345). The in vitro transcribed gRNA was purified with the MEGAclear kit (Invitrogen AM1908). A single-stranded donor template oligonucleotide (ssOligo) was designed containing the C458A mutation, silent mutation of the PAM site, and a silent Hpy188III restriction site (5’ <named-content content-type="sequence">CGGATTGTGGTCCAGAAGAAAGACGGCGCTGACTGGATTCGCTGTACAGTCTGCCACACTGAGATC</named-content> 3’). Superovulation was induced in 3- to 5-week-old female C57BL/6J donor mice by treatment with 5IU of pregnant mare’s serum gonadotropin (Hölzel Diagnostika OPPA01037) and 5IU of human chorionic gonadotropin (Intervet, GesmbH); females were mated and zygotes were isolated in M2 media (Merck Milipore MR-015P-D). Zygotes were cultured in KSOM medium (Cosmo Bio Co., Ltd RB074) and cytosolically injected with 100 ng/µl Cas9 mRNA (Merck CAS9MRNA-1EA), 50 ng/µl gRNA, and 200 ng/µl ssOligo; injected zygotes were transferred to pseudo-pregnant females. Correct knock-in was confirmed in founder mice by Sanger sequencing. Routine genotyping of mice was done by digestion with Hpy188III (NEB R0622) and analysis on a 2% agarose gel.</p></sec><sec id="s4-18"><title>Mouse husbandry</title><p>C57BL/6J <italic>Rbck1<sup>C458A/C458A</sup></italic> mice were bred and kept at the IMBA/IMP animal house. All mice were bred and maintained in accordance with ethical animal license protocols complying with the Austrian and European legislation. Animal procedures were covered by the license 568809/2013/18.</p></sec><sec id="s4-19"><title>Isolation and immortalization of MEFs</title><p>MEF isolation and immortalization methods are described elsewhere (<xref ref-type="bibr" rid="bib19">Fennell et al., 2019</xref>). Briefly, primary MEFs were isolated at E13.5 following standard protocols. Pregnant females were sacrificed, and the uterus was extracted. Isolated tissue from the embryo was digested with trypsin (Thermo Fisher 25300054) for 5 min at 37°C and digest was quenched with Dulbecco’s modified eagle’s medium (DMEM) containing 10% (v/v) FCS. Cells were collected by centrifugation and cultured at 37°C, 5% CO<sub>2</sub> in DMEM (Sigma D5648) supplemented with 10% (v/v) FCS, 0.2 U/ml penicillin, 0.2 µg/ml streptomycin (Merck P0781), and 2 mM L-glutamine (Gibco 25030–024). MEFs were immortalized with SV40 large T-antigen by transfection using GeneJuice transfection reagent (Merck Millipore 70967). Our routine mycoplasma tests showed negative results for these cells.</p></sec><sec id="s4-20"><title>TNF stimulation of MEFs</title><p>1.6 × 106 MEFs were seeded in a 10 cm cell culture dish and grown overnight, serum-starved overnight in DMEM supplemented with 0.2% (v/v) FCS, 0.2 U/ml penicillin, 0.2 µg/ml streptomycin, and 2 mM L-glutamine. The following day cells were stimulated for 15 min with 50 ng/ml mouse TNF (Peprotech).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr Gijs Versteeg (Max F Perutz Laboratories, Austria) and Katrin Rittinger (The Crick Institute, UK) for critical discussion and feedback on the work and manuscript. We thank Mayu Seida (MIB, Kyushu University, Japan), Olga Olszanska, Steven Dupart, and Lilian Fennell (IMBA, Austria) for their technical support. We also thank Richard Imre, Elisabeth Roitinger, and Otto Hudecz for mass spectrometry data analysis, as well as Ines Steinmacher and Susanne Opravil for technical support (the Protein Chemistry Facility, IMP/IMBA core facility, Austria). Samples were prepared and data was recorded at the EM Facility of the Vienna BioCenter Core Facilities GmbH (VBCF, Austria). We thank the IMP/IMBA core facilities, including Transgenic Service, Comparative Medicine, and Molecular Biology Service for their technical support. Baculovirus production and insect cell culture was performed by the Protein Technologies Facility (VBCF, Austria). Research at the Ikeda Lab is supported by JSPS KAKENHI (Grant Number JP 18K19959, JP 21H04777, JP 21H00288) and the Austrian Academy of Sciences. Research at the Haselbach Lab is supported by Boehringer Ingelheim. Research at the Clausen Lab is supported by the FFG Headquarter Grant 852936 and Boehringer Ingelheim. Research at the Kukura Lab is supported by the ERC Starting Grant PHOTOMASS 819593.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>a consultant in Refeyn Ltd.</p></fn><fn fn-type="COI-statement" id="conf3"><p>an employee of JT Inc.</p></fn><fn fn-type="COI-statement" id="conf4"><p>academic founder, consultant, and shareholder in Refeyn Ltd.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Resources, Data curation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Visualization</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Data curation, Validation, Visualization</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con12"><p>Data curation, Formal analysis, Supervision, Funding acquisition, Methodology</p></fn><fn fn-type="con" id="con13"><p>Formal analysis, Supervision, Funding acquisition, Methodology</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were bred and maintained in accordance with ethical animal license protocols complying with the Austrian and European legislation. Animal procedures were covered by the license 568809/2013/18.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Population masses determined by mass photometry.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60660-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Unique inter-protein cross-links detected by linear ubiquitin chain assembly complex (LUBAC) 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium tetrafluoroborate (DMTMM ) XL-MS analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60660-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Unique intra-protein cross-links detected by linear ubiquitin chain assembly complex (LUBAC) 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium tetrafluoroborate (DMTMM) XL-MS analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60660-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Primers.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-60660-supp4-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-60660-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data besides the structural data and the mass spec data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Supplementary Tables 1-3.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>F</given-names></name><name><surname>Rodriguez</surname><given-names>Carvajal A</given-names></name><name><surname>Haselbach</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Linear Ubiquitin Chain Assembly Complex</data-title><source>Electron Microscopy Data Bank</source><pub-id assigning-authority="EMDB" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pdbe/entry/emdb/EMD-11054">EMD-11054</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>F</given-names></name><name><surname>Vogel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>The linear ubiquitin chain assembly complex LUBAC generates heterotypic ubiquitin chains</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD019771">PXD019771</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akutsu</surname> <given-names>M</given-names></name><name><surname>Ye</surname> <given-names>Y</given-names></name><name><surname>Virdee</surname> <given-names>S</given-names></name><name><surname>Chin</surname> <given-names>JW</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains</article-title><source>PNAS</source><volume>108</volume><fpage>2228</fpage><lpage>2233</lpage><pub-id pub-id-type="doi">10.1073/pnas.1015287108</pub-id><pub-id pub-id-type="pmid">21266548</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhogaraju</surname> <given-names>S</given-names></name><name><surname>Kalayil</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Bonn</surname> <given-names>F</given-names></name><name><surname>Colby</surname> <given-names>T</given-names></name><name><surname>Matic</surname> <given-names>I</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phosphoribosylation of ubiquitin promotes serine ubiquitination and impairs conventional ubiquitination</article-title><source>Cell</source><volume>167</volume><fpage>1636</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.11.019</pub-id><pub-id pub-id-type="pmid">27912065</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bremm</surname> <given-names>A</given-names></name><name><surname>Freund</surname> <given-names>SM</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>17</volume><fpage>939</fpage><lpage>947</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1873</pub-id><pub-id pub-id-type="pmid">20622874</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>AF</given-names></name><name><surname>Pinto</surname> <given-names>MP</given-names></name><name><surname>Grou</surname> <given-names>CP</given-names></name><name><surname>Alencastre</surname> <given-names>IS</given-names></name><name><surname>Fransen</surname> <given-names>M</given-names></name><name><surname>Sá-Miranda</surname> <given-names>C</given-names></name><name><surname>Azevedo</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ubiquitination of mammalian Pex5p, the peroxisomal import receptor</article-title><source>Journal of Biological Chemistry</source><volume>282</volume><fpage>31267</fpage><lpage>31272</lpage><pub-id pub-id-type="doi">10.1074/jbc.M706325200</pub-id><pub-id pub-id-type="pmid">17726030</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>MC</given-names></name><name><surname>Maclean</surname> <given-names>B</given-names></name><name><surname>Burke</surname> <given-names>R</given-names></name><name><surname>Amodei</surname> <given-names>D</given-names></name><name><surname>Ruderman</surname> <given-names>DL</given-names></name><name><surname>Neumann</surname> <given-names>S</given-names></name><name><surname>Gatto</surname> <given-names>L</given-names></name><name><surname>Fischer</surname> <given-names>B</given-names></name><name><surname>Pratt</surname> <given-names>B</given-names></name><name><surname>Egertson</surname> <given-names>J</given-names></name><name><surname>Hoff</surname> <given-names>K</given-names></name><name><surname>Kessner</surname> <given-names>D</given-names></name><name><surname>Tasman</surname> <given-names>N</given-names></name><name><surname>Shulman</surname> <given-names>N</given-names></name><name><surname>Frewen</surname> <given-names>B</given-names></name><name><surname>Baker</surname> <given-names>TA</given-names></name><name><surname>Brusniak</surname> <given-names>MY</given-names></name><name><surname>Paulse</surname> <given-names>C</given-names></name><name><surname>Creasy</surname> <given-names>D</given-names></name><name><surname>Flashner</surname> <given-names>L</given-names></name><name><surname>Kani</surname> <given-names>K</given-names></name><name><surname>Moulding</surname> <given-names>C</given-names></name><name><surname>Seymour</surname> <given-names>SL</given-names></name><name><surname>Nuwaysir</surname> <given-names>LM</given-names></name><name><surname>Lefebvre</surname> <given-names>B</given-names></name><name><surname>Kuhlmann</surname> <given-names>F</given-names></name><name><surname>Roark</surname> <given-names>J</given-names></name><name><surname>Rainer</surname> <given-names>P</given-names></name><name><surname>Detlev</surname> <given-names>S</given-names></name><name><surname>Hemenway</surname> <given-names>T</given-names></name><name><surname>Huhmer</surname> <given-names>A</given-names></name><name><surname>Langridge</surname> <given-names>J</given-names></name><name><surname>Connolly</surname> <given-names>B</given-names></name><name><surname>Chadick</surname> <given-names>T</given-names></name><name><surname>Holly</surname> <given-names>K</given-names></name><name><surname>Eckels</surname> <given-names>J</given-names></name><name><surname>Deutsch</surname> <given-names>EW</given-names></name><name><surname>Moritz</surname> <given-names>RL</given-names></name><name><surname>Katz</surname> <given-names>JE</given-names></name><name><surname>Agus</surname> <given-names>DB</given-names></name><name><surname>MacCoss</surname> <given-names>M</given-names></name><name><surname>Tabb</surname> <given-names>DL</given-names></name><name><surname>Mallick</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A cross-platform toolkit for mass spectrometry and proteomics</article-title><source>Nature Biotechnology</source><volume>30</volume><fpage>918</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1038/nbt.2377</pub-id><pub-id pub-id-type="pmid">23051804</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname> <given-names>L</given-names></name><name><surname>Ran</surname> <given-names>FA</given-names></name><name><surname>Cox</surname> <given-names>D</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Barretto</surname> <given-names>R</given-names></name><name><surname>Habib</surname> <given-names>N</given-names></name><name><surname>Hsu</surname> <given-names>PD</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Jiang</surname> <given-names>W</given-names></name><name><surname>Marraffini</surname> <given-names>LA</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Multiplex genome engineering using CRISPR/Cas systems</article-title><source>Science</source><volume>339</volume><fpage>819</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1126/science.1231143</pub-id><pub-id pub-id-type="pmid">23287718</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Cesare</surname> <given-names>V</given-names></name><name><surname>Carbajo Lopez</surname> <given-names>D</given-names></name><name><surname>Mabbitt</surname> <given-names>PD</given-names></name><name><surname>Fletcher</surname> <given-names>AJ</given-names></name><name><surname>Soetens</surname> <given-names>M</given-names></name><name><surname>Antico</surname> <given-names>O</given-names></name><name><surname>Wood</surname> <given-names>NT</given-names></name><name><surname>Virdee</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Deubiquitinating enzyme amino acid profiling reveals a class of ubiquitin esterases</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2006947118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2006947118</pub-id><pub-id pub-id-type="pmid">33479176</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doblmann</surname> <given-names>J</given-names></name><name><surname>Dusberger</surname> <given-names>F</given-names></name><name><surname>Imre</surname> <given-names>R</given-names></name><name><surname>Hudecz</surname> <given-names>O</given-names></name><name><surname>Stanek</surname> <given-names>F</given-names></name><name><surname>Mechtler</surname> <given-names>K</given-names></name><name><surname>Dürnberger</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>apQuant: Accurate Label-Free Quantification by Quality Filtering</article-title><source>Journal of Proteome Research</source><volume>18</volume><fpage>535</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00113</pub-id><pub-id pub-id-type="pmid">30351950</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorfer</surname> <given-names>V</given-names></name><name><surname>Pichler</surname> <given-names>P</given-names></name><name><surname>Stranzl</surname> <given-names>T</given-names></name><name><surname>Stadlmann</surname> <given-names>J</given-names></name><name><surname>Taus</surname> <given-names>T</given-names></name><name><surname>Winkler</surname> <given-names>S</given-names></name><name><surname>Mechtler</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MS Amanda, a universal identification algorithm optimized for high accuracy tandem mass spectra</article-title><source>Journal of Proteome Research</source><volume>13</volume><fpage>3679</fpage><lpage>3684</lpage><pub-id pub-id-type="doi">10.1021/pr500202e</pub-id><pub-id pub-id-type="pmid">24909410</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einarson</surname> <given-names>MB</given-names></name><name><surname>Pugacheva</surname> <given-names>EN</given-names></name><name><surname>Orlinick</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Identification of Protein-Protein interactions with Glutathione-S-Transferase (GST) Fusion proteins</article-title><source>Cold Spring Harbor Protocols</source><volume>2007</volume><elocation-id>pdb.top11</elocation-id><pub-id pub-id-type="doi">10.1101/pdb.top11</pub-id><pub-id pub-id-type="pmid">21357153</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname> <given-names>PR</given-names></name><name><surname>Leske</surname> <given-names>D</given-names></name><name><surname>Hrdinka</surname> <given-names>M</given-names></name><name><surname>Bagola</surname> <given-names>K</given-names></name><name><surname>Fiil</surname> <given-names>BK</given-names></name><name><surname>McLaughlin</surname> <given-names>SH</given-names></name><name><surname>Wagstaff</surname> <given-names>J</given-names></name><name><surname>Volkmar</surname> <given-names>N</given-names></name><name><surname>Christianson</surname> <given-names>JC</given-names></name><name><surname>Kessler</surname> <given-names>BM</given-names></name><name><surname>Freund</surname> <given-names>SM</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name><name><surname>Gyrd-Hansen</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling</article-title><source>Molecular Cell</source><volume>63</volume><fpage>990</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.08.001</pub-id><pub-id pub-id-type="pmid">27591049</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elton</surname> <given-names>L</given-names></name><name><surname>Carpentier</surname> <given-names>I</given-names></name><name><surname>Staal</surname> <given-names>J</given-names></name><name><surname>Driege</surname> <given-names>Y</given-names></name><name><surname>Haegman</surname> <given-names>M</given-names></name><name><surname>Beyaert</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling</article-title><source>FEBS Journal</source><volume>283</volume><fpage>403</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1111/febs.13597</pub-id><pub-id pub-id-type="pmid">26573773</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmerich</surname> <given-names>CH</given-names></name><name><surname>Cohen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Optimising methods for the preservation, capture and identification of ubiquitin chains and ubiquitylated proteins by immunoblotting</article-title><source>Biochemical and Biophysical Research Communications</source><volume>466</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2015.08.109</pub-id><pub-id pub-id-type="pmid">26325464</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enesa</surname> <given-names>K</given-names></name><name><surname>Zakkar</surname> <given-names>M</given-names></name><name><surname>Chaudhury</surname> <given-names>H</given-names></name><name><surname>Luong</surname> <given-names>leA</given-names></name><name><surname>Rawlinson</surname> <given-names>L</given-names></name><name><surname>Mason</surname> <given-names>JC</given-names></name><name><surname>Haskard</surname> <given-names>DO</given-names></name><name><surname>Dean</surname> <given-names>JL</given-names></name><name><surname>Evans</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling</article-title><source>The Journal of Biological Cchemistry</source><volume>283</volume><fpage>7036</fpage><lpage>7045</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708690200</pub-id><pub-id pub-id-type="pmid">18178551</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname> <given-names>HP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy</article-title><source>Biological Procedures Online</source><volume>11</volume><fpage>32</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1007/s12575-009-9008-x</pub-id><pub-id pub-id-type="pmid">19495910</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>PC</given-names></name><name><surname>Taylor</surname> <given-names>ER</given-names></name><name><surname>Coadwell</surname> <given-names>J</given-names></name><name><surname>Heyninck</surname> <given-names>K</given-names></name><name><surname>Beyaert</surname> <given-names>R</given-names></name><name><surname>Kilshaw</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Isolation and characterization of two novel A20-like proteins</article-title><source>Biochemical Journal</source><volume>357</volume><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1042/bj3570617</pub-id><pub-id pub-id-type="pmid">11463333</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>PC</given-names></name><name><surname>Smith</surname> <given-names>TS</given-names></name><name><surname>Lai</surname> <given-names>MJ</given-names></name><name><surname>Williams</surname> <given-names>MG</given-names></name><name><surname>Burke</surname> <given-names>DF</given-names></name><name><surname>Heyninck</surname> <given-names>K</given-names></name><name><surname>Kreike</surname> <given-names>MM</given-names></name><name><surname>Beyaert</surname> <given-names>R</given-names></name><name><surname>Blundell</surname> <given-names>TL</given-names></name><name><surname>Kilshaw</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A novel type of deubiquitinating enzyme</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>23180</fpage><lpage>23186</lpage><pub-id pub-id-type="doi">10.1074/jbc.M301863200</pub-id><pub-id pub-id-type="pmid">12682062</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fennell</surname> <given-names>LM</given-names></name><name><surname>Rahighi</surname> <given-names>S</given-names></name><name><surname>Ikeda</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Linear ubiquitin chain-binding domains</article-title><source>The FEBS Journal</source><volume>285</volume><fpage>2746</fpage><lpage>2761</lpage><pub-id pub-id-type="doi">10.1111/febs.14478</pub-id><pub-id pub-id-type="pmid">29679476</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Fennell</surname> <given-names>LM</given-names></name><name><surname>Deszcz</surname> <given-names>L</given-names></name><name><surname>Schleiffer</surname> <given-names>A</given-names></name><name><surname>Mechtler</surname> <given-names>K</given-names></name><name><surname>Kavirayani</surname> <given-names>A</given-names></name><name><surname>Ikeda</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Site-specific ubiquitination of the E3 ligase HOIP regulates cell death and immune signaling</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/742544</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiil</surname> <given-names>BK</given-names></name><name><surname>Damgaard</surname> <given-names>RB</given-names></name><name><surname>Wagner</surname> <given-names>SA</given-names></name><name><surname>Keusekotten</surname> <given-names>K</given-names></name><name><surname>Fritsch</surname> <given-names>M</given-names></name><name><surname>Bekker-Jensen</surname> <given-names>S</given-names></name><name><surname>Mailand</surname> <given-names>N</given-names></name><name><surname>Choudhary</surname> <given-names>C</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name><name><surname>Gyrd-Hansen</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>OTULIN restricts Met1-linked ubiquitination to control innate immune signaling</article-title><source>Molecular Cell</source><volume>50</volume><fpage>818</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.06.004</pub-id><pub-id pub-id-type="pmid">23806334</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>L</given-names></name><name><surname>Rappsilber</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Quirks of Error Estimation in Cross-Linking/Mass Spectrometry</article-title><source>Analytical Chemistry</source><volume>89</volume><fpage>3829</fpage><lpage>3833</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.6b03745</pub-id><pub-id pub-id-type="pmid">28267312</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname> <given-names>H</given-names></name><name><surname>Tokunaga</surname> <given-names>A</given-names></name><name><surname>Shimizu</surname> <given-names>S</given-names></name><name><surname>Whiting</surname> <given-names>AL</given-names></name><name><surname>Aguilar-Alonso</surname> <given-names>F</given-names></name><name><surname>Takagi</surname> <given-names>K</given-names></name><name><surname>Walinda</surname> <given-names>E</given-names></name><name><surname>Sasaki</surname> <given-names>Y</given-names></name><name><surname>Shimokawa</surname> <given-names>T</given-names></name><name><surname>Mizushima</surname> <given-names>T</given-names></name><name><surname>Ohki</surname> <given-names>I</given-names></name><name><surname>Ariyoshi</surname> <given-names>M</given-names></name><name><surname>Tochio</surname> <given-names>H</given-names></name><name><surname>Bernal</surname> <given-names>F</given-names></name><name><surname>Shirakawa</surname> <given-names>M</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cooperative Domain Formation by Homologous Motifs in HOIL-1L and SHARPIN Plays A Crucial Role in LUBAC Stabilization</article-title><source>Cell Reports</source><volume>23</volume><fpage>1192</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.112</pub-id><pub-id pub-id-type="pmid">29694895</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuseya</surname> <given-names>Y</given-names></name><name><surname>Fujita</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Ohtake</surname> <given-names>F</given-names></name><name><surname>Nishide</surname> <given-names>A</given-names></name><name><surname>Sasaki</surname> <given-names>K</given-names></name><name><surname>Saeki</surname> <given-names>Y</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Takahashi</surname> <given-names>R</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The HOIL-1L ligase modulates immune signalling and cell death via monoubiquitination of LUBAC</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>663</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0517-9</pub-id><pub-id pub-id-type="pmid">32393887</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname> <given-names>B</given-names></name><name><surname>Cordier</surname> <given-names>SM</given-names></name><name><surname>Schmukle</surname> <given-names>AC</given-names></name><name><surname>Emmerich</surname> <given-names>CH</given-names></name><name><surname>Rieser</surname> <given-names>E</given-names></name><name><surname>Haas</surname> <given-names>TL</given-names></name><name><surname>Webb</surname> <given-names>AI</given-names></name><name><surname>Rickard</surname> <given-names>JA</given-names></name><name><surname>Anderton</surname> <given-names>H</given-names></name><name><surname>Wong</surname> <given-names>WW</given-names></name><name><surname>Nachbur</surname> <given-names>U</given-names></name><name><surname>Gangoda</surname> <given-names>L</given-names></name><name><surname>Warnken</surname> <given-names>U</given-names></name><name><surname>Purcell</surname> <given-names>AW</given-names></name><name><surname>Silke</surname> <given-names>J</given-names></name><name><surname>Walczak</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Linear ubiquitination prevents inflammation and regulates immune signalling</article-title><source>Nature</source><volume>471</volume><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1038/nature09816</pub-id><pub-id pub-id-type="pmid">21455173</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giese</surname> <given-names>SH</given-names></name><name><surname>Fischer</surname> <given-names>L</given-names></name><name><surname>Rappsilber</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A Study into the Collision-induced Dissociation (CID) Behavior of Cross-Linked Peptides</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>15</volume><fpage>1094</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1074/mcp.M115.049296</pub-id><pub-id pub-id-type="pmid">26719564</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname> <given-names>M</given-names></name><name><surname>Zimniak</surname> <given-names>T</given-names></name><name><surname>Kahraman</surname> <given-names>A</given-names></name><name><surname>Herzog</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>xVis: a web server for the schematic visualization and interpretation of crosslink-derived spatial restraints</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W362</fpage><lpage>W369</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv463</pub-id><pub-id pub-id-type="pmid">25956653</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hospenthal</surname> <given-names>MK</given-names></name><name><surname>Mevissen</surname> <given-names>TET</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest)</article-title><source>Nature Protocols</source><volume>10</volume><fpage>349</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.018</pub-id><pub-id pub-id-type="pmid">25633630</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname> <given-names>F</given-names></name><name><surname>Deribe</surname> <given-names>YL</given-names></name><name><surname>Skånland</surname> <given-names>SS</given-names></name><name><surname>Stieglitz</surname> <given-names>B</given-names></name><name><surname>Grabbe</surname> <given-names>C</given-names></name><name><surname>Franz-Wachtel</surname> <given-names>M</given-names></name><name><surname>van Wijk</surname> <given-names>SJ</given-names></name><name><surname>Goswami</surname> <given-names>P</given-names></name><name><surname>Nagy</surname> <given-names>V</given-names></name><name><surname>Terzic</surname> <given-names>J</given-names></name><name><surname>Tokunaga</surname> <given-names>F</given-names></name><name><surname>Androulidaki</surname> <given-names>A</given-names></name><name><surname>Nakagawa</surname> <given-names>T</given-names></name><name><surname>Pasparakis</surname> <given-names>M</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name><name><surname>Sundberg</surname> <given-names>JP</given-names></name><name><surname>Schaefer</surname> <given-names>L</given-names></name><name><surname>Rittinger</surname> <given-names>K</given-names></name><name><surname>Macek</surname> <given-names>B</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis</article-title><source>Nature</source><volume>471</volume><fpage>637</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1038/nature09814</pub-id><pub-id pub-id-type="pmid">21455181</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Linear ubiquitination signals in adaptive immune responses</article-title><source>Immunological Reviews</source><volume>266</volume><fpage>222</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1111/imr.12300</pub-id><pub-id pub-id-type="pmid">26085218</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwai</surname> <given-names>K</given-names></name><name><surname>Tokunaga</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Linear polyubiquitination: a new regulator of NF-kappaB activation</article-title><source>EMBO Reports</source><volume>10</volume><fpage>706</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/embor.2009.144</pub-id><pub-id pub-id-type="pmid">19543231</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Käll</surname> <given-names>L</given-names></name><name><surname>Canterbury</surname> <given-names>JD</given-names></name><name><surname>Weston</surname> <given-names>J</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name><name><surname>MacCoss</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Semi-supervised learning for peptide identification from shotgun proteomics datasets</article-title><source>Nature Methods</source><volume>4</volume><fpage>923</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1038/nmeth1113</pub-id><pub-id pub-id-type="pmid">17952086</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelsall</surname> <given-names>IR</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Knebel</surname> <given-names>A</given-names></name><name><surname>Arthur</surname> <given-names>JSC</given-names></name><name><surname>Cohen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The E3 ligase HOIL-1 catalyses ester bond formation between ubiquitin and components of the Myddosome in mammalian cells</article-title><source>PNAS</source><volume>116</volume><fpage>13293</fpage><lpage>13298</lpage><pub-id pub-id-type="doi">10.1073/pnas.1905873116</pub-id><pub-id pub-id-type="pmid">31209050</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirisako</surname> <given-names>T</given-names></name><name><surname>Kamei</surname> <given-names>K</given-names></name><name><surname>Murata</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Fukumoto</surname> <given-names>H</given-names></name><name><surname>Kanie</surname> <given-names>M</given-names></name><name><surname>Sano</surname> <given-names>S</given-names></name><name><surname>Tokunaga</surname> <given-names>F</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A ubiquitin ligase complex assembles linear polyubiquitin chains</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>4877</fpage><lpage>4887</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601360</pub-id><pub-id pub-id-type="pmid">17006537</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komander</surname> <given-names>D</given-names></name><name><surname>Rape</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The ubiquitin code</article-title><source>Annual Review of Biochemistry</source><volume>81</volume><fpage>203</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-060310-170328</pub-id><pub-id pub-id-type="pmid">22524316</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupka</surname> <given-names>S</given-names></name><name><surname>De Miguel</surname> <given-names>D</given-names></name><name><surname>Draber</surname> <given-names>P</given-names></name><name><surname>Martino</surname> <given-names>L</given-names></name><name><surname>Surinova</surname> <given-names>S</given-names></name><name><surname>Rittinger</surname> <given-names>K</given-names></name><name><surname>Walczak</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes</article-title><source>Cell Reports</source><volume>16</volume><fpage>2271</fpage><lpage>2280</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.07.086</pub-id><pub-id pub-id-type="pmid">27545878</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leitner</surname> <given-names>A</given-names></name><name><surname>Joachimiak</surname> <given-names>LA</given-names></name><name><surname>Unverdorben</surname> <given-names>P</given-names></name><name><surname>Walzthoeni</surname> <given-names>T</given-names></name><name><surname>Frydman</surname> <given-names>J</given-names></name><name><surname>Förster</surname> <given-names>F</given-names></name><name><surname>Aebersold</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chemical cross-linking/mass spectrometry targeting acidic residues in proteins and protein complexes</article-title><source>PNAS</source><volume>111</volume><fpage>9455</fpage><lpage>9460</lpage><pub-id pub-id-type="doi">10.1073/pnas.1320298111</pub-id><pub-id pub-id-type="pmid">24938783</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licchesi</surname> <given-names>JD</given-names></name><name><surname>Mieszczanek</surname> <given-names>J</given-names></name><name><surname>Mevissen</surname> <given-names>TE</given-names></name><name><surname>Rutherford</surname> <given-names>TJ</given-names></name><name><surname>Akutsu</surname> <given-names>M</given-names></name><name><surname>Virdee</surname> <given-names>S</given-names></name><name><surname>El Oualid</surname> <given-names>F</given-names></name><name><surname>Chin</surname> <given-names>JW</given-names></name><name><surname>Ovaa</surname> <given-names>H</given-names></name><name><surname>Bienz</surname> <given-names>M</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>19</volume><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2169</pub-id><pub-id pub-id-type="pmid">22157957</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Fu</surname> <given-names>T</given-names></name><name><surname>Hu</surname> <given-names>S</given-names></name><name><surname>Zhou</surname> <given-names>Z</given-names></name><name><surname>Pan</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural Insights into SHARPIN-Mediated Activation of HOIP for the Linear Ubiquitin Chain Assembly</article-title><source>Cell Reports</source><volume>21</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.031</pub-id><pub-id pub-id-type="pmid">28978479</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luong</surname> <given-names>leA</given-names></name><name><surname>Fragiadaki</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>J</given-names></name><name><surname>Boyle</surname> <given-names>J</given-names></name><name><surname>Lutz</surname> <given-names>J</given-names></name><name><surname>Dean</surname> <given-names>JL</given-names></name><name><surname>Harten</surname> <given-names>S</given-names></name><name><surname>Ashcroft</surname> <given-names>M</given-names></name><name><surname>Walmsley</surname> <given-names>SR</given-names></name><name><surname>Haskard</surname> <given-names>DO</given-names></name><name><surname>Maxwell</surname> <given-names>PH</given-names></name><name><surname>Walczak</surname> <given-names>H</given-names></name><name><surname>Pusey</surname> <given-names>C</given-names></name><name><surname>Evans</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination</article-title><source>Circulation Research</source><volume>112</volume><fpage>1583</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.300119</pub-id><pub-id pub-id-type="pmid">23564640</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClellan</surname> <given-names>AJ</given-names></name><name><surname>Laugesen</surname> <given-names>SH</given-names></name><name><surname>Ellgaard</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cellular functions and molecular mechanisms of non-lysine ubiquitination</article-title><source>Open Biology</source><volume>9</volume><elocation-id>190147</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.190147</pub-id><pub-id pub-id-type="pmid">31530095</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDowell</surname> <given-names>GS</given-names></name><name><surname>Philpott</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Non-canonical ubiquitylation: mechanisms and consequences</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>45</volume><fpage>1833</fpage><lpage>1842</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2013.05.026</pub-id><pub-id pub-id-type="pmid">23732108</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mevissen</surname> <given-names>TE</given-names></name><name><surname>Hospenthal</surname> <given-names>MK</given-names></name><name><surname>Geurink</surname> <given-names>PP</given-names></name><name><surname>Elliott</surname> <given-names>PR</given-names></name><name><surname>Akutsu</surname> <given-names>M</given-names></name><name><surname>Arnaudo</surname> <given-names>N</given-names></name><name><surname>Ekkebus</surname> <given-names>R</given-names></name><name><surname>Kulathu</surname> <given-names>Y</given-names></name><name><surname>Wauer</surname> <given-names>T</given-names></name><name><surname>El Oualid</surname> <given-names>F</given-names></name><name><surname>Freund</surname> <given-names>SM</given-names></name><name><surname>Ovaa</surname> <given-names>H</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis</article-title><source>Cell</source><volume>154</volume><fpage>169</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.046</pub-id><pub-id pub-id-type="pmid">23827681</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mevissen</surname> <given-names>TET</given-names></name><name><surname>Kulathu</surname> <given-names>Y</given-names></name><name><surname>Mulder</surname> <given-names>MPC</given-names></name><name><surname>Geurink</surname> <given-names>PP</given-names></name><name><surname>Maslen</surname> <given-names>SL</given-names></name><name><surname>Gersch</surname> <given-names>M</given-names></name><name><surname>Elliott</surname> <given-names>PR</given-names></name><name><surname>Burke</surname> <given-names>JE</given-names></name><name><surname>van Tol</surname> <given-names>BDM</given-names></name><name><surname>Akutsu</surname> <given-names>M</given-names></name><name><surname>Oualid</surname> <given-names>FE</given-names></name><name><surname>Kawasaki</surname> <given-names>M</given-names></name><name><surname>Freund</surname> <given-names>SMV</given-names></name><name><surname>Ovaa</surname> <given-names>H</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne</article-title><source>Nature</source><volume>538</volume><fpage>402</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1038/nature19836</pub-id><pub-id pub-id-type="pmid">27732584</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhold</surname> <given-names>J</given-names></name><name><surname>Radakovics</surname> <given-names>K</given-names></name><name><surname>Lehner</surname> <given-names>A</given-names></name><name><surname>Weissmann</surname> <given-names>F</given-names></name><name><surname>Garcia</surname> <given-names>MQ</given-names></name><name><surname>Romero</surname> <given-names>MC</given-names></name><name><surname>Berrow</surname> <given-names>NS</given-names></name><name><surname>Stolt-Bergner</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GoldenBac: a simple, highly efficient, and widely applicable system for construction of multi-gene expression vectors for use with the baculovirus expression vector system</article-title><source>BMC Biotechnology</source><volume>20</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1186/s12896-020-00616-z</pub-id><pub-id pub-id-type="pmid">32398045</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noad</surname> <given-names>J</given-names></name><name><surname>von der Malsburg</surname> <given-names>A</given-names></name><name><surname>Pathe</surname> <given-names>C</given-names></name><name><surname>Michel</surname> <given-names>MA</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name><name><surname>Randow</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>LUBAC-synthesized linear ubiquitin chains restrict cytosol-invading bacteria by activating autophagy and NF-κB</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>17063</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.63</pub-id><pub-id pub-id-type="pmid">28481331</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pao</surname> <given-names>KC</given-names></name><name><surname>Wood</surname> <given-names>NT</given-names></name><name><surname>Knebel</surname> <given-names>A</given-names></name><name><surname>Rafie</surname> <given-names>K</given-names></name><name><surname>Stanley</surname> <given-names>M</given-names></name><name><surname>Mabbitt</surname> <given-names>PD</given-names></name><name><surname>Sundaramoorthy</surname> <given-names>R</given-names></name><name><surname>Hofmann</surname> <given-names>K</given-names></name><name><surname>van Aalten</surname> <given-names>DMF</given-names></name><name><surname>Virdee</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity</article-title><source>Nature</source><volume>556</volume><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0026-1</pub-id><pub-id pub-id-type="pmid">29643511</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peltzer</surname> <given-names>N</given-names></name><name><surname>Rieser</surname> <given-names>E</given-names></name><name><surname>Taraborrelli</surname> <given-names>L</given-names></name><name><surname>Draber</surname> <given-names>P</given-names></name><name><surname>Darding</surname> <given-names>M</given-names></name><name><surname>Pernaute</surname> <given-names>B</given-names></name><name><surname>Shimizu</surname> <given-names>Y</given-names></name><name><surname>Sarr</surname> <given-names>A</given-names></name><name><surname>Draberova</surname> <given-names>H</given-names></name><name><surname>Montinaro</surname> <given-names>A</given-names></name><name><surname>Martinez-Barbera</surname> <given-names>JP</given-names></name><name><surname>Silke</surname> <given-names>J</given-names></name><name><surname>Rodriguez</surname> <given-names>TA</given-names></name><name><surname>Walczak</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death</article-title><source>Cell Reports</source><volume>9</volume><fpage>153</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.066</pub-id><pub-id pub-id-type="pmid">25284787</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peltzer</surname> <given-names>N</given-names></name><name><surname>Darding</surname> <given-names>M</given-names></name><name><surname>Montinaro</surname> <given-names>A</given-names></name><name><surname>Draber</surname> <given-names>P</given-names></name><name><surname>Draberova</surname> <given-names>H</given-names></name><name><surname>Kupka</surname> <given-names>S</given-names></name><name><surname>Rieser</surname> <given-names>E</given-names></name><name><surname>Fisher</surname> <given-names>A</given-names></name><name><surname>Hutchinson</surname> <given-names>C</given-names></name><name><surname>Taraborrelli</surname> <given-names>L</given-names></name><name><surname>Hartwig</surname> <given-names>T</given-names></name><name><surname>Lafont</surname> <given-names>E</given-names></name><name><surname>Haas</surname> <given-names>TL</given-names></name><name><surname>Shimizu</surname> <given-names>Y</given-names></name><name><surname>Böiers</surname> <given-names>C</given-names></name><name><surname>Sarr</surname> <given-names>A</given-names></name><name><surname>Rickard</surname> <given-names>J</given-names></name><name><surname>Alvarez-Diaz</surname> <given-names>S</given-names></name><name><surname>Ashworth</surname> <given-names>MT</given-names></name><name><surname>Beal</surname> <given-names>A</given-names></name><name><surname>Enver</surname> <given-names>T</given-names></name><name><surname>Bertin</surname> <given-names>J</given-names></name><name><surname>Kaiser</surname> <given-names>W</given-names></name><name><surname>Strasser</surname> <given-names>A</given-names></name><name><surname>Silke</surname> <given-names>J</given-names></name><name><surname>Bouillet</surname> <given-names>P</given-names></name><name><surname>Walczak</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis</article-title><source>Nature</source><volume>557</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0064-8</pub-id><pub-id pub-id-type="pmid">29695863</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Sheedlo</surname> <given-names>MJ</given-names></name><name><surname>Yu</surname> <given-names>K</given-names></name><name><surname>Tan</surname> <given-names>Y</given-names></name><name><surname>Nakayasu</surname> <given-names>ES</given-names></name><name><surname>Das</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Luo</surname> <given-names>ZQ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ubiquitination independent of E1 and E2 enzymes by bacterial effectors</article-title><source>Nature</source><volume>533</volume><fpage>120</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nature17657</pub-id><pub-id pub-id-type="pmid">27049943</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahighi</surname> <given-names>S</given-names></name><name><surname>Ikeda</surname> <given-names>F</given-names></name><name><surname>Kawasaki</surname> <given-names>M</given-names></name><name><surname>Akutsu</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Kato</surname> <given-names>R</given-names></name><name><surname>Kensche</surname> <given-names>T</given-names></name><name><surname>Uejima</surname> <given-names>T</given-names></name><name><surname>Bloor</surname> <given-names>S</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name><name><surname>Randow</surname> <given-names>F</given-names></name><name><surname>Wakatsuki</surname> <given-names>S</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation</article-title><source>Cell</source><volume>136</volume><fpage>1098</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.03.007</pub-id><pub-id pub-id-type="pmid">19303852</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittinger</surname> <given-names>K</given-names></name><name><surname>Ikeda</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Linear ubiquitin chains: enzymes, mechanisms and biology</article-title><source>Open Biology</source><volume>7</volume><elocation-id>170026</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.170026</pub-id><pub-id pub-id-type="pmid">28446710</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivkin</surname> <given-names>E</given-names></name><name><surname>Almeida</surname> <given-names>SM</given-names></name><name><surname>Ceccarelli</surname> <given-names>DF</given-names></name><name><surname>Juang</surname> <given-names>YC</given-names></name><name><surname>MacLean</surname> <given-names>TA</given-names></name><name><surname>Srikumar</surname> <given-names>T</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Dunham</surname> <given-names>WH</given-names></name><name><surname>Fukumura</surname> <given-names>R</given-names></name><name><surname>Xie</surname> <given-names>G</given-names></name><name><surname>Gondo</surname> <given-names>Y</given-names></name><name><surname>Raught</surname> <given-names>B</given-names></name><name><surname>Gingras</surname> <given-names>AC</given-names></name><name><surname>Sicheri</surname> <given-names>F</given-names></name><name><surname>Cordes</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis</article-title><source>Nature</source><volume>498</volume><fpage>318</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1038/nature12296</pub-id><pub-id pub-id-type="pmid">23708998</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohou</surname> <given-names>A</given-names></name><name><surname>Grigorieff</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CTFFIND4: Fast and accurate defocus estimation from electron micrographs</article-title><source>Journal of Structural Biology</source><volume>192</volume><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2015.08.008</pub-id><pub-id pub-id-type="pmid">26278980</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>Y</given-names></name><name><surname>Fujita</surname> <given-names>H</given-names></name><name><surname>Yoshikawa</surname> <given-names>A</given-names></name><name><surname>Yamashita</surname> <given-names>M</given-names></name><name><surname>Yamagata</surname> <given-names>A</given-names></name><name><surname>Kaiser</surname> <given-names>SE</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name><name><surname>Fukai</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex</article-title><source>PNAS</source><volume>108</volume><fpage>20520</fpage><lpage>20525</lpage><pub-id pub-id-type="doi">10.1073/pnas.1109088108</pub-id><pub-id pub-id-type="pmid">22139374</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>RELION: implementation of a Bayesian approach to cryo-EM structure determination</article-title><source>Journal of Structural Biology</source><volume>180</volume><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2012.09.006</pub-id><pub-id pub-id-type="pmid">23000701</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>A Bayesian view on cryo-EM structure determination</article-title><source>Journal of Molecular Biology</source><volume>415</volume><fpage>406</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2011.11.010</pub-id><pub-id pub-id-type="pmid">22100448</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlicher</surname> <given-names>L</given-names></name><name><surname>Wissler</surname> <given-names>M</given-names></name><name><surname>Preiss</surname> <given-names>F</given-names></name><name><surname>Brauns-Schubert</surname> <given-names>P</given-names></name><name><surname>Jakob</surname> <given-names>C</given-names></name><name><surname>Dumit</surname> <given-names>V</given-names></name><name><surname>Borner</surname> <given-names>C</given-names></name><name><surname>Dengjel</surname> <given-names>J</given-names></name><name><surname>Maurer</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death</article-title><source>EMBO Reports</source><volume>17</volume><fpage>1485</fpage><lpage>1497</lpage><pub-id pub-id-type="doi">10.15252/embr.201642592</pub-id><pub-id pub-id-type="pmid">27458237</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>D</given-names></name><name><surname>Mukherjee</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Gonzalez</surname> <given-names>A</given-names></name><name><surname>Bonn</surname> <given-names>F</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Rogov</surname> <given-names>VV</given-names></name><name><surname>Heinz</surname> <given-names>M</given-names></name><name><surname>Stolz</surname> <given-names>A</given-names></name><name><surname>Hummer</surname> <given-names>G</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>Luo</surname> <given-names>ZQ</given-names></name><name><surname>Bhogaraju</surname> <given-names>S</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulation of Phosphoribosyl-Linked serine ubiquitination by deubiquitinases DupA and DupB</article-title><source>Molecular Cell</source><volume>77</volume><fpage>164</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.10.019</pub-id><pub-id pub-id-type="pmid">31732457</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname> <given-names>LM</given-names></name><name><surname>Monty</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. application to crude preparations of sulfite and hydroxylamine reductases</article-title><source>Biochimica Et Biophysica Acta (BBA) - Biophysics Including Photosynthesis</source><volume>112</volume><fpage>346</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/0926-6585(66)90333-5</pub-id><pub-id pub-id-type="pmid">5329026</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname> <given-names>JJ</given-names></name><name><surname>Monteferrario</surname> <given-names>D</given-names></name><name><surname>Noordermeer</surname> <given-names>SM</given-names></name><name><surname>van Dijk</surname> <given-names>WJ</given-names></name><name><surname>van der Reijden</surname> <given-names>BA</given-names></name><name><surname>Sixma</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>3833</fpage><lpage>3844</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.217</pub-id><pub-id pub-id-type="pmid">22863777</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname> <given-names>JJ</given-names></name><name><surname>van Dijk</surname> <given-names>WJ</given-names></name><name><surname>El Atmioui</surname> <given-names>D</given-names></name><name><surname>Merkx</surname> <given-names>R</given-names></name><name><surname>Ovaa</surname> <given-names>H</given-names></name><name><surname>Sixma</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Target specificity of the E3 ligase LUBAC for ubiquitin and NEMO relies on different minimal requirements</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>31728</fpage><lpage>31737</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.495846</pub-id><pub-id pub-id-type="pmid">24030825</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Sonn-Segev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantifying the heterogeneity of macromolecular machines by mass photometry</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/864553</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stieglitz</surname> <given-names>B</given-names></name><name><surname>Morris-Davies</surname> <given-names>AC</given-names></name><name><surname>Koliopoulos</surname> <given-names>MG</given-names></name><name><surname>Christodoulou</surname> <given-names>E</given-names></name><name><surname>Rittinger</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LUBAC synthesizes linear ubiquitin chains via a thioester intermediate</article-title><source>EMBO Reports</source><volume>13</volume><fpage>840</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.105</pub-id><pub-id pub-id-type="pmid">22791023</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stieglitz</surname> <given-names>B</given-names></name><name><surname>Rana</surname> <given-names>RR</given-names></name><name><surname>Koliopoulos</surname> <given-names>MG</given-names></name><name><surname>Morris-Davies</surname> <given-names>AC</given-names></name><name><surname>Schaeffer</surname> <given-names>V</given-names></name><name><surname>Christodoulou</surname> <given-names>E</given-names></name><name><surname>Howell</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>NR</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name><name><surname>Rittinger</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP</article-title><source>Nature</source><volume>503</volume><fpage>422</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1038/nature12638</pub-id><pub-id pub-id-type="pmid">24141947</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swatek</surname> <given-names>KN</given-names></name><name><surname>Usher</surname> <given-names>JL</given-names></name><name><surname>Kueck</surname> <given-names>AF</given-names></name><name><surname>Gladkova</surname> <given-names>C</given-names></name><name><surname>Mevissen</surname> <given-names>TET</given-names></name><name><surname>Pruneda</surname> <given-names>JN</given-names></name><name><surname>Skern</surname> <given-names>T</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Insights into ubiquitin chain architecture using Ub-clipping</article-title><source>Nature</source><volume>572</volume><fpage>533</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1482-y</pub-id><pub-id pub-id-type="pmid">31413367</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatematsu</surname> <given-names>K</given-names></name><name><surname>Yoshimoto</surname> <given-names>N</given-names></name><name><surname>Okajima</surname> <given-names>T</given-names></name><name><surname>Tanizawa</surname> <given-names>K</given-names></name><name><surname>Kuroda</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase Cbeta</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>11575</fpage><lpage>11585</lpage><pub-id pub-id-type="doi">10.1074/jbc.M706961200</pub-id><pub-id pub-id-type="pmid">18303026</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taus</surname> <given-names>T</given-names></name><name><surname>Köcher</surname> <given-names>T</given-names></name><name><surname>Pichler</surname> <given-names>P</given-names></name><name><surname>Paschke</surname> <given-names>C</given-names></name><name><surname>Schmidt</surname> <given-names>A</given-names></name><name><surname>Henrich</surname> <given-names>C</given-names></name><name><surname>Mechtler</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Universal and confident phosphorylation site localization using phosphoRS</article-title><source>Journal of Proteome Research</source><volume>10</volume><fpage>5354</fpage><lpage>5362</lpage><pub-id pub-id-type="doi">10.1021/pr200611n</pub-id><pub-id pub-id-type="pmid">22073976</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname> <given-names>F</given-names></name><name><surname>Sakata</surname> <given-names>S</given-names></name><name><surname>Saeki</surname> <given-names>Y</given-names></name><name><surname>Satomi</surname> <given-names>Y</given-names></name><name><surname>Kirisako</surname> <given-names>T</given-names></name><name><surname>Kamei</surname> <given-names>K</given-names></name><name><surname>Nakagawa</surname> <given-names>T</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Murata</surname> <given-names>S</given-names></name><name><surname>Yamaoka</surname> <given-names>S</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name><name><surname>Takao</surname> <given-names>T</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation</article-title><source>Nature Cell Biology</source><volume>11</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1038/ncb1821</pub-id><pub-id pub-id-type="pmid">19136968</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname> <given-names>F</given-names></name><name><surname>Nakagawa</surname> <given-names>T</given-names></name><name><surname>Nakahara</surname> <given-names>M</given-names></name><name><surname>Saeki</surname> <given-names>Y</given-names></name><name><surname>Taniguchi</surname> <given-names>M</given-names></name><name><surname>Sakata</surname> <given-names>S</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Nakano</surname> <given-names>H</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex</article-title><source>Nature</source><volume>471</volume><fpage>633</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nature09815</pub-id><pub-id pub-id-type="pmid">21455180</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Well</surname> <given-names>EM</given-names></name><name><surname>Bader</surname> <given-names>V</given-names></name><name><surname>Patra</surname> <given-names>M</given-names></name><name><surname>Sánchez-Vicente</surname> <given-names>A</given-names></name><name><surname>Meschede</surname> <given-names>J</given-names></name><name><surname>Furthmann</surname> <given-names>N</given-names></name><name><surname>Schnack</surname> <given-names>C</given-names></name><name><surname>Blusch</surname> <given-names>A</given-names></name><name><surname>Longworth</surname> <given-names>J</given-names></name><name><surname>Petrasch-Parwez</surname> <given-names>E</given-names></name><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Trümbach</surname> <given-names>D</given-names></name><name><surname>Angersbach</surname> <given-names>L</given-names></name><name><surname>Showkat</surname> <given-names>C</given-names></name><name><surname>Sehr</surname> <given-names>DA</given-names></name><name><surname>Berlemann</surname> <given-names>LA</given-names></name><name><surname>Goldmann</surname> <given-names>P</given-names></name><name><surname>Clement</surname> <given-names>AM</given-names></name><name><surname>Behl</surname> <given-names>C</given-names></name><name><surname>Woerner</surname> <given-names>AC</given-names></name><name><surname>Saft</surname> <given-names>C</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Ellrichmann</surname> <given-names>G</given-names></name><name><surname>Gold</surname> <given-names>R</given-names></name><name><surname>Dittmar</surname> <given-names>G</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Tatzelt</surname> <given-names>J</given-names></name><name><surname>Winklhofer</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A protein quality control pathway regulated by linear ubiquitination</article-title><source>The EMBO Journal</source><volume>38</volume><elocation-id>e100730</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2018100730</pub-id><pub-id pub-id-type="pmid">30886048</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Wijk</surname> <given-names>SJL</given-names></name><name><surname>Fricke</surname> <given-names>F</given-names></name><name><surname>Herhaus</surname> <given-names>L</given-names></name><name><surname>Gupta</surname> <given-names>J</given-names></name><name><surname>Hötte</surname> <given-names>K</given-names></name><name><surname>Pampaloni</surname> <given-names>F</given-names></name><name><surname>Grumati</surname> <given-names>P</given-names></name><name><surname>Kaulich</surname> <given-names>M</given-names></name><name><surname>Sou</surname> <given-names>YS</given-names></name><name><surname>Komatsu</surname> <given-names>M</given-names></name><name><surname>Greten</surname> <given-names>FR</given-names></name><name><surname>Fulda</surname> <given-names>S</given-names></name><name><surname>Heilemann</surname> <given-names>M</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Linear ubiquitination of cytosolic Salmonella Typhimurium activates NF-κB and restricts bacterial proliferation</article-title><source>Nature Microbiology</source><volume>2</volume><elocation-id>17066</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.66</pub-id><pub-id pub-id-type="pmid">28481361</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vosper</surname> <given-names>JM</given-names></name><name><surname>McDowell</surname> <given-names>GS</given-names></name><name><surname>Hindley</surname> <given-names>CJ</given-names></name><name><surname>Fiore-Heriche</surname> <given-names>CS</given-names></name><name><surname>Kucerova</surname> <given-names>R</given-names></name><name><surname>Horan</surname> <given-names>I</given-names></name><name><surname>Philpott</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>15458</fpage><lpage>15468</lpage><pub-id pub-id-type="doi">10.1074/jbc.M809366200</pub-id><pub-id pub-id-type="pmid">19336407</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname> <given-names>S</given-names></name><name><surname>Carpentier</surname> <given-names>I</given-names></name><name><surname>Rogov</surname> <given-names>V</given-names></name><name><surname>Kreike</surname> <given-names>M</given-names></name><name><surname>Ikeda</surname> <given-names>F</given-names></name><name><surname>Löhr</surname> <given-names>F</given-names></name><name><surname>Wu</surname> <given-names>CJ</given-names></name><name><surname>Ashwell</surname> <given-names>JD</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>Dikic</surname> <given-names>I</given-names></name><name><surname>Beyaert</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins</article-title><source>Oncogene</source><volume>27</volume><fpage>3739</fpage><lpage>3745</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1211042</pub-id><pub-id pub-id-type="pmid">18212736</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname> <given-names>SA</given-names></name><name><surname>Satpathy</surname> <given-names>S</given-names></name><name><surname>Beli</surname> <given-names>P</given-names></name><name><surname>Choudhary</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes</article-title><source>The EMBO Journal</source><volume>35</volume><fpage>1868</fpage><lpage>1884</lpage><pub-id pub-id-type="doi">10.15252/embj.201694300</pub-id><pub-id pub-id-type="pmid">27307491</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Herr</surname> <given-names>RA</given-names></name><name><surname>Chua</surname> <given-names>WJ</given-names></name><name><surname>Lybarger</surname> <given-names>L</given-names></name><name><surname>Wiertz</surname> <given-names>EJ</given-names></name><name><surname>Hansen</surname> <given-names>TH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3</article-title><source>Journal of Cell Biology</source><volume>177</volume><fpage>613</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1083/jcb.200611063</pub-id><pub-id pub-id-type="pmid">17502423</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>C</given-names></name><name><surname>van den Berg</surname> <given-names>M</given-names></name><name><surname>Sprenger</surname> <given-names>RR</given-names></name><name><surname>Distel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A Conserved Cysteine Is Essential for Pex4p-dependent Ubiquitination of the Peroxisomal Import Receptor Pex5p</article-title><source>Journal of Biological Chemistry</source><volume>282</volume><fpage>22534</fpage><lpage>22543</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702038200</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagi</surname> <given-names>H</given-names></name><name><surname>Ishimoto</surname> <given-names>K</given-names></name><name><surname>Hiromoto</surname> <given-names>T</given-names></name><name><surname>Fujita</surname> <given-names>H</given-names></name><name><surname>Mizushima</surname> <given-names>T</given-names></name><name><surname>Uekusa</surname> <given-names>Y</given-names></name><name><surname>Yagi-Utsumi</surname> <given-names>M</given-names></name><name><surname>Kurimoto</surname> <given-names>E</given-names></name><name><surname>Noda</surname> <given-names>M</given-names></name><name><surname>Uchiyama</surname> <given-names>S</given-names></name><name><surname>Tokunaga</surname> <given-names>F</given-names></name><name><surname>Iwai</surname> <given-names>K</given-names></name><name><surname>Kato</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex</article-title><source>EMBO Reports</source><volume>13</volume><fpage>462</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.24</pub-id><pub-id pub-id-type="pmid">22430200</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>Y</given-names></name><name><surname>Akutsu</surname> <given-names>M</given-names></name><name><surname>Reyes-Turcu</surname> <given-names>F</given-names></name><name><surname>Enchev</surname> <given-names>RI</given-names></name><name><surname>Wilkinson</surname> <given-names>KD</given-names></name><name><surname>Komander</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21</article-title><source>EMBO Reports</source><volume>12</volume><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1038/embor.2011.17</pub-id><pub-id pub-id-type="pmid">21399617</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>G</given-names></name><name><surname>Hundt</surname> <given-names>N</given-names></name><name><surname>Cole</surname> <given-names>D</given-names></name><name><surname>Fineberg</surname> <given-names>A</given-names></name><name><surname>Andrecka</surname> <given-names>J</given-names></name><name><surname>Tyler</surname> <given-names>A</given-names></name><name><surname>Olerinyova</surname> <given-names>A</given-names></name><name><surname>Ansari</surname> <given-names>A</given-names></name><name><surname>Marklund</surname> <given-names>EG</given-names></name><name><surname>Collier</surname> <given-names>MP</given-names></name><name><surname>Chandler</surname> <given-names>SA</given-names></name><name><surname>Tkachenko</surname> <given-names>O</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Crispin</surname> <given-names>M</given-names></name><name><surname>Billington</surname> <given-names>N</given-names></name><name><surname>Takagi</surname> <given-names>Y</given-names></name><name><surname>Sellers</surname> <given-names>JR</given-names></name><name><surname>Eichmann</surname> <given-names>C</given-names></name><name><surname>Selenko</surname> <given-names>P</given-names></name><name><surname>Frey</surname> <given-names>L</given-names></name><name><surname>Riek</surname> <given-names>R</given-names></name><name><surname>Galpin</surname> <given-names>MR</given-names></name><name><surname>Struwe</surname> <given-names>WB</given-names></name><name><surname>Benesch</surname> <given-names>JLP</given-names></name><name><surname>Kukura</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Quantitative mass imaging of single biological macromolecules</article-title><source>Science</source><volume>360</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1126/science.aar5839</pub-id><pub-id pub-id-type="pmid">29700264</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivanov</surname> <given-names>J</given-names></name><name><surname>Nakane</surname> <given-names>T</given-names></name><name><surname>Forsberg</surname> <given-names>BO</given-names></name><name><surname>Kimanius</surname> <given-names>D</given-names></name><name><surname>Hagen</surname> <given-names>WJ</given-names></name><name><surname>Lindahl</surname> <given-names>E</given-names></name><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>New tools for automated high-resolution cryo-EM structure determination in RELION-3</article-title><source>eLife</source><volume>7</volume><elocation-id>e42166</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.42166</pub-id><pub-id pub-id-type="pmid">30412051</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60660.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Martin</surname><given-names>Andreas</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lander</surname> <given-names>Gabe</given-names> </name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This work provides important new insights into the architecture of LUBAC and the activity of its HOIL-1L E3 ligase component in synthesizing heterotypic, branched ubiquitin chains through oxyester-bond formation. The spatial proximity of HOIL-1L's catalytic domain and the catalytic domain of HOIP, another E3 ligase within LUBAC, indicates an intriguing ubiquitin relay mechanism that may be prevalent among E3 ligases.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The linear ubiquitin chain assembly complex LUBAC generates heterotypic ubiquitin chains&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Cynthia Wolberger as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Gabe Lander (Scripps) (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>The editors have judged that your manuscript is of significant interest, yet some additional experiments are required before publication, as described. We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts.</p><p>Summary:</p><p>This manuscript by Carvajal et al. provides novel insights into HOIL-1L's activity within the LUBAC complex in synthesizing heterotypic, branched ubiquitin chains through oxyester-bond formation. The authors successfully produced and isolated recombinant LUBAC, containing full length HOIL-1L, HOIP, and SHARPIN, and although the intrinsic flexibility prevented a higher-resolution 3D-structure determination, negative-stain EM combined with crosslinking mass spec revealed important new information about the architecture of this complex. Based on the observed spatial proximity of HOIL-1L's and HOIP's catalytic RBR domains, the authors propose an intriguing ubiquitin relay mechanism between these E3 ligases in LUBAC.</p><p>The reviewers agreed that this work represents an important contribution to the field, as it corroborates and extends previous findings of HOIL-1L's non-lysine esterification activity. However, the advance and impact could be improved by some additional experiments to further strengthen the mechanistic conclusions.</p><p>Essential revisions:</p><p>1) Although the authors present the first 3D reconstruction of LUBAC, the contribution of this low resolution model to this study seems questionable. The 2D analyses demonstrate the substantial flexibility of the complex, and projections generated from the 3D structure only marginally match the selected projections shown in Figure 2. If EM analyses are meant to support the biochemical reconstitution of the active LUBAC complex, then the 2D class averages are more than sufficient. Based on the 2D data and the fact that there are many class averages that are not recapitulated by 2D projections (and vice versa), it is highly unlikely that the purified complex is consistent with a single 3D structure. If the authors were able to use negative stain of complexes, where individual subunits contained identifiable tags (e.g. GFP, MBP), to localize subunits and corroborate the crosslink-MS, perhaps a 3D model would be appropriate, but as it stands, the utility of the 3D density seems moot.</p><p>2) The circus plot in Figure 3B to represent the crosslinking-MS data could be improved by &quot;weighing&quot; the quantity or confidence of observed crosslinks, such that attention is drawn to the most important and obvious linkages, for instance by using different line widths, color shades, or the presentation of multiple plots at distinct cutoff values.</p><p>Furthermore, the pair-wise domain representation in Figure 3C-E gives the impression that a single domain (or even single residue) is found crosslinking to almost every part of the opposing protein (a straight line in the plot which contains many dots) in several instances. This could similarly benefit from thresholding or a more cautious description. Can it truly be inferred that the RBR's and NZF's of HOIP and HOIL-1L are forming a catalytic center, when grey linker-regions are over-represented in the plot?</p><p>The authors should discuss the promiscuous crosslinking of linker regions and whether this may indicate high dynamics that could be related to the difficulties in solving better-resolution structures. Also, it may also be visually more appealing to represent non-domain grey regions by a thinner line than known domains in all representations of Figures 3A-3E and 6D.</p><p>Based on their crosslinking results, the authors emphasize the interaction of the RBR domains of HOIP and HOIL-1L and speculate that LUBAC may have a single catalytic center. However, since multiple contacts between LUBAC domains are detected (Figures 3B-E), the authors need to explain why they focused on this particular one. It will be interesting to analyze the effect of E2 or E2~Ub on crosslinking.</p><p>3) Thr12 and Thr55 were identified as potential ester linkage sites within poly-Ub species, but their mutation did not abolish the formation of hydroxylamine-sensitive bands. The authors should state the observed ubiquitin-sequence coverage in their mass spec experiment and which regions were not covered.</p><p>4) The authors hypothesize that a key function of the HOIL-1 esterification activity is to form heterotypic chains. While this might be the case, the alternative hypothesis of HOIL-1 priming substrates with ester-linked ubiquitins that are then linearly extended by HOIP seems also equally valid, especially because multiple substrates have been reported to be modified with linear chains, but HOIP appears to be tailored to modify only an ubiquitin substrate. The authors should discuss this alternative hypothesis and why both systems might be important.</p><p>In further support of substrates potentially being the most abundant ester-linked species, NEMO-enriched linear chains from TNF treated cells show a much more pronounced collapse compared to the ester-linked Ub-Ub linkages produced in the absence of substrate in vitro. It would greatly strengthen the paper if the authors could add a recombinant substrate (e.g. IRAK1/2 or MyD88) to the in vitro reaction.</p><p>5) In Figure 4B, why could the mixed LUBAC subunits generate a linear chain, but not an oxyester-linked branched Ub4? Do they form a high molecular weight complex that can be detected by gel filtration?</p><p>6) In Figures 4E and 5A, it is interesting that Cezanne and vOTU could cleave ester-linked branched Ub4, although the molecular bases for these reactions remain unclear. Are the LUBAC-generated, hydroxylamine-sensitive His-Ub3 and Ub2 shown in Figure 5B cleavable by Cezanne and vOTU?</p><p>7) To confirm that the residual oligomeric Ub species after OTULIN treatment (Figure 4E) are exclusively ester-linked, a subsequent hydroxylamine treatment step should be performed.</p><p>8) Finally, the suggestion that HOIP-HOIL Ub relay might be at play is exciting and implies that E3-mediated Ub relay might be a prevalent process. In principal it should be possible to test this by impairing E2 binding to the RING1 domain in HOIL in LUBAC. A steric mutation (e.g. X to Arg) would be a more elegant approach than a zinc-coordinating cysteine mutation. If relay is at play, then such mutated LUBAC should still be able to form ester linkages.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60660.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Although the authors present the first 3D reconstruction of LUBAC, the contribution of this low resolution model to this study seems questionable. The 2D analyses demonstrate the substantial flexibility of the complex, and projections generated from the 3D structure only marginally match the selected projections shown in Figure 2. If EM analyses are meant to support the biochemical reconstitution of the active LUBAC complex, then the 2D class averages are more than sufficient. Based on the 2D data and the fact that there are many class averages that are not recapitulated by 2D projections (and vice versa), it is highly unlikely that the purified complex is consistent with a single 3D structure.</p></disp-quote><p>We agree with the reviewers that the 2D class averages indicate a degree of flexibility in the complex. The 2D class averages show an asymmetric crescent structure where the mass of the complex is focused at either end with a thinner linker region that is expected to be the source of potential structural flexibility. As such, the 3D model in our first submission may indeed represent an average of a few conformers that differ by the degree of pivoting around the central linker region. However, the 2D class averages are not suggestive of multiple highly variable structural configurations in the complex that would jeopardize the accuracy of the model at the low resolution of negative staining. Nevertheless, to address the reviewers’ concern, we further refined the 3D model of the complex and arrived at a reconstruction that more accurately reflects the 2D class averages (Figure 2B new). Moreover, the projections obtained from the new model match the 2D class averages of the complex much better than those originally presented (Figure 2C new). Therefore, we present a new 3D refined model as a more accurate reconstruction of the LUBAC complex.</p><disp-quote content-type="editor-comment"><p>If the authors were able to use negative stain of complexes, where individual subunits contained identifiable tags (e.g. GFP, MBP), to localize subunits and corroborate the crosslink-MS, perhaps a 3D model would be appropriate, but as it stands, the utility of the 3D density seems moot.</p></disp-quote><p>We certainly agree with the reviewers that identification of the catalytic C-termini of HOIL-1L and HOIP in the structure would corroborate the crosslinking-MS data and increase the usefulness of the structure. We therefore tagged the HOIP or HOIL-1L with an identifiable C-terminal GFP tag to localize their respective C-terminal regions in the structure. The GFP-tagged complexes could be purified and the purity of the preparations could be determined by mass photometry measurements showing the precise expected mass shift from the GFP tag as shown in Author response image 1.</p><fig id="sa2fig1"><label>Author response image 1.</label><caption><title>GFP-tagged LUBAC purification.</title><p>(A) Purification of LUBAC containing GFP-tagged HOIP or HOIL-1L. (B) Mass photometry measurement of GFP-tagged LUBAC showing 27 kDa shift in the monomeric (250kDa) and dimeric (500kDa) mass of the complex.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-resp-fig1-v2.tif"/></fig><p>Unfortunately, despite the quality of the purifications, we could not reliably identify the GFP tag in the obtained 2D class averages or 3D reconstructions as shown in Author response image 2.</p><fig id="sa2fig2"><label>Author response image 2.</label><caption><title>GFP-tagged LUBAC class averages.</title><p>(A) Class averages of GFP-tagged LUBAC. (B) Selected class averages that may show GFP tag.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-resp-fig2-v2.tif"/></fig><p>We could not determine the exact reason for the absence of the tag from the negative stain data but we believe it could be the result of either the tag being too flexible with respect to LUBAC for visualization or because the C-termini of the proteins may not be resolved in our model. We appreciate the limitations of our presented model; nevertheless we have included the 3D reconstruction as it represents the first 3D model of the LUBAC complex, which is an important advancement in the field.</p><disp-quote content-type="editor-comment"><p>2) The circus plot in Figure 3B to represent the crosslinking-MS data could be improved by &quot;weighing&quot; the quantity or confidence of observed crosslinks, such that attention is drawn to the most important and obvious linkages, for instance by using different line widths, color shades, or the presentation of multiple plots at distinct cutoff values.</p></disp-quote><p>A score for each crosslink is generated by the software employed. However, multiple cross-linked peptides were detected for all plotted crosslinks. Hence, across all three datasets there are multiple scores for all detected crosslinks falling within the same range. It would therefore not be possible to select scores in an unbiased manner for the plot nor to make a clear visual distinction in the figure given that the scores lie in similar ranges for all the plotted crosslinks.</p><disp-quote content-type="editor-comment"><p>Furthermore, the pair-wise domain representation in Figure 3C-E gives the impression that a single domain (or even single residue) is found crosslinking to almost every part of the opposing protein (a straight line in the plot which contains many dots) in several instances. This could similarly benefit from thresholding or a more cautious description. Can it truly be inferred that the RBR's and NZF's of HOIP and HOIL-1L are forming a catalytic center, when grey linker-regions are over-represented in the plot?</p><p>The authors should discuss the promiscuous crosslinking of linker regions and whether this may indicate high dynamics that could be related to the difficulties in solving better-resolution structures.</p></disp-quote><p>As the reviewers raise an important point we tried to improve our data by further purifying LUBAC with a gel filtration step prior to crosslinking. Under the new conditions we could not observe any appreciable change in the crosslinking pattern as exemplified in the pair-wise plot for HOIP-to-HOIL-1L inter-protein crosslinks (Author response image 3).</p><fig id="sa2fig3"><label>Author response image 3.</label><caption><title>XL-MS results with additional purification step prior to crosslinking.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-resp-fig3-v2.tif"/></fig><p>Each of the three proteins had one residue that was observed to crosslink indiscriminately to all other domains giving rise to the observed pattern on the pair-wise representations. These residues were HOIL-1L K174, SHARPIN K318, and HOIP K454/458. We argue that these residues are likely found on flexible regions of the proteins thus giving rise to the high levels of crosslinking to all domains in the complex. Indeed, foldindex prediction of HOIL-1L shows that unfolded regions match with these highly crossed-linked regions (Author response image 4). This issue is likely further exacerbated by the dimerization of LUBAC. Therefore, we do not expect all the crosslinks formed by these residues to be structurally relevant. However, as they are a product of the experimental set up they cannot be filtered out during data analysis. Hence, they were left in the figures in order to present an unbiased picture of the data. Nevertheless, the accuracy of the selectively crosslinking regions, including the NZF and RBR domains of HOIL-1L and HOIP, is independent to the background generated by promiscuously crosslinking residues. We are confident in our inference over the catalytic center of LUBAC, as it is supported by our biochemical data. As shown in figure 7, mutation of the catalytic Cys of HOIP inhibits the catalytic activity of HOIL-1L; similarly mutation of the NZF of HOIL-1L abrogates its catalytic activity.</p><fig id="sa2fig4"><label>Author response image 4.</label><caption><title>Fold-index plot of human HOIL-1L.</title><p>Regions in HOIL-1L observed to cross-link mostly reside within the low fold-index (unfolded) area in the shown plot.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60660-resp-fig4-v2.tif"/></fig><p>We appreciate that our discussion pertaining to these promiscuous crosslinks may not have been sufficient and have updated the text to reflect the reviewers’ concerns as follows:</p><p>“We detected some highly crosslinking residues that formed crosslinks indiscriminately to all subunits of all proteins. […] The presence of flexible regions on the three LUBAC components may be related to the difficulties in determining the structures of full-length HOIP, HOIL-1L, and SHARPIN thus far.”</p><disp-quote content-type="editor-comment"><p>Also, it may also be visually more appealing to represent non-domain grey regions by a thinner line than known domains in all representations of Figures 3A-3E and 6D.</p><p>Based on their crosslinking results, the authors emphasize the interaction of the RBR domains of HOIP and HOIL-1L and speculate that LUBAC may have a single catalytic center. However, since multiple contacts between LUBAC domains are detected (Figures 3B-E), the authors need to explain why they focused on this particular one. It will be interesting to analyze the effect of E2 or E2~Ub on crosslinking.</p></disp-quote><p>We thank the reviewers for their observation. We also thank the reviewers for interesting suggestions on E2 and Ub-loaded E2 to include in the XL-MS analysis. Due to high complexity of the cross links as described as above, we decided not to include E2 in the new experiments. To explain why we focused on these crosslinks, we have updated the text as follows:</p><p>“Interestingly, we observed crosslinks between the HOIL-1L RING1 and HOIP RING1/LDD domains, as well as between the HOIL-1L RING2 and the HOIP RING1/IBR/RING2/LDD domains, which could indicate that the two enzymes have spatially connected catalytic activities. Additionally, HOIL-1L intra-protein crosslinks were formed between its NZF domain and its RING1/IBR/RING2 domains, which could implicate the HOIL-1L NZF domain of unknown function in the catalytic action of HOIL-1L.”</p><disp-quote content-type="editor-comment"><p>3) Thr12 and Thr55 were identified as potential ester linkage sites within poly-Ub species, but their mutation did not abolish the formation of hydroxylamine-sensitive bands. The authors should state the observed ubiquitin-sequence coverage in their mass spec experiment and which regions were not covered.</p></disp-quote><p>We had almost full sequence coverage of ubiquitin in the mass spectrometry samples where Thr 12 and Thr55 were identified as ester-linkage sites. Only the final three amino acids of ubiquitin were not detected in their un-conjugated form, which is expected due to the high sensitivity of the C-terminal LRLRGG peptide to tryptic digest. We have updated the text to reflect the coverage of the ubiquitin sequence as follows:</p><p>“MS/MS spectra of GG-conjugated dipeptides at residues Thr12 and Thr55 of ubiquitin were detected from these samples, in which there was complete coverage of the ubiquitin amino acid sequence of 1-73”.</p><p>Based on this, we figure that the reason why mutations at Thr12 and Thr55 in Ub did not abolish the formation of hydroxyamine-sensitive bands is that there are alternative ubiquitination sites in the Ub Thr12/Thr55 mutant (such as Ser20 shown by Kelsall et al.), which we could not detect in our assays by using wild-type Ub.</p><disp-quote content-type="editor-comment"><p>4) The authors hypothesize that a key function of the HOIL-1 esterification activity is to form heterotypic chains. While this might be the case, the alternative hypothesis of HOIL-1 priming substrates with ester-linked ubiquitins that are then linearly extended by HOIP seems also equally valid, especially because multiple substrates have been reported to be modified with linear chains, but HOIP appears to be tailored to modify only an ubiquitin substrate. The authors should discuss this alternative hypothesis and why both systems might be important.</p><p>In further support of substrates potentially being the most abundant ester-linked species, NEMO-enriched linear chains from TNF treated cells show a much more pronounced collapse compared to the ester-linked Ub-Ub linkages produced in the absence of substrate in vitro. It would greatly strengthen the paper if the authors could add a recombinant substrate (e.g. IRAK1/2 or MyD88) to the in vitro reaction.</p></disp-quote><p>The reviewers raise an important point concerning the architecture of the heterotypic ubiquitin chains and the LUBAC ligase responsible for substrate ubiquitination. Therefore, we carried out an in vitro ubiquitination reaction including the model LUBAC substrate NEMO and subjected the reactions to hydroxylamine treatment (Figure 6B). Our results show that the majority of the signal from the ubiquitinated substrate is unaffected by hydroxylamine, indicating that substrate-conjugated chains are branched but not attached to the substrate via oxyester bonds. We have discussed the in vivo and in vitro chain branching data as follows:</p><p>“Our analysis of chain branching on substrate-conjugated ubiquitin chains suggests that the oxyester branch points of the chain are located distally from the substrate. […] One explanation could be that there are other factors present in cells that assist HOIL-1L in the process of chain branching and which remain hitherto unidentified.”</p><disp-quote content-type="editor-comment"><p>5) In Figure 4B, why could the mixed LUBAC subunits generate a linear chain, but not an oxyester-linked branched Ub4? Do they form a high molecular weight complex that can be detected by gel filtration?</p></disp-quote><p>As the reviewers suggest, we believe that individually purified and mixed HOIP, HOIL-1L, and SHARPIN do not adequately assemble the LUBAC complex. The result being that, while HOIP auto-inhibition is released and linear chains can be assembled, the more catalytically complex action of HOIL-1L in chain branching is not possible. Perhaps this results from improper spatial arrangement of the RBR domains of HOIP and HOIL-1L resulting in interruption of the proposed Cys relay (Figure 8). To support this claim, we carried out mass photometry measurements from the individually purified LUBAC components mixed at an equimolar ratio of the three components, as was done for the comparative in vitro assay (Supplementary Figure 5 new). In line with our hypothesis we, did not observe the 220 kDa peak corresponding to assembled LUBAC nor the 440 kDa peak corresponding to dimerized LUBAC, indicating that mixed LUBAC components cannot adequately assemble the LUBAC complex.</p><disp-quote content-type="editor-comment"><p>6) In Figures 4E and 5A, it is interesting that Cezanne and vOTU could cleave ester-linked branched Ub4, although the molecular bases for these reactions remain unclear. Are the LUBAC-generated, hydroxylamine-sensitive His-Ub3 and Ub2 shown in Figure 5B cleavable by Cezanne and vOTU?</p></disp-quote><p>The reviewers ask an interesting question regarding the ability of the DUBs Cezanne and vOTU to cleave small ubiquitin polymers exclusively assembled with oxyester linkages. As suggested, we carried out a UbiCRest experiment of LUBAC-assembled His6-ubiquitin polymers. Our results show that the short oxyester-linked ubiquitin polymers are indeed sensitive to cleavage by both the tested DUBs (Supplementary Figure 6B new).</p><disp-quote content-type="editor-comment"><p>7) To confirm that the residual oligomeric Ub species after OTULIN treatment (Figure 4E) are exclusively ester-linked, a subsequent hydroxylamine treatment step should be performed.</p></disp-quote><p>We carried out OTULIN UbiCRest analysis of LUBAC-assembled poly-ubiquitin chains followed by hydroxylamine treatment, as the reviewers suggested (Supplementary Figure 6A new). Our results were consistent with a ubiquitin polymer containing predominantly M1 bonds connected to short branches via oxyester bonds. The majority of the poly-ubiquitin signal proved to be sensitive to cleavage by OTULIN, while a small residue of di- and tri-ubiquitin was resistant to OTULIN cleavage but degraded by subsequent treatment with hydroxylamine.</p><disp-quote content-type="editor-comment"><p>8) Finally, the suggestion that HOIP-HOIL Ub relay might be at play is exciting and implies that E3-mediated Ub relay might be a prevalent process. In principal it should be possible to test this by impairing E2 binding to the RING1 domain in HOIL in LUBAC. A steric mutation (e.g. X to Arg) would be a more elegant approach than a zinc-coordinating cysteine mutation. If relay is at play, then such mutated LUBAC should still be able to form ester linkages.</p></disp-quote><p>We agree with the reviewers that finding a way to impair E2 binding to HOIL-1L would be a great way to test the proposed Cys relay. Unfortunately, while we have tried to plan such an experiment, at present there are too many unknown variables to permit such a mutant from being made. The principal issue is with accurately predicting the E2 binding site of HOIL-1L. Some available structures of other RBR ligases such as HHARI and Parkin co-crystalized with an E2 enzyme show a binding loop on the RING1 domain (PDB: 5tte, 5udh, 6djw, 6n13). However, the only available structure of the HOIP RBR with an E2 (PDB: 5edv) shows a second E2-binding site at the RING2 and LDD domains. This raises the issue of whether a simple RING1 mutation in HOIL-1L would indeed prevent E2 binding by HOIL-1L or whether there is an additional E2 binding site at the RING2 domain. Furthermore, we carried out a multiple-sequence alignment of RBR family ligases and noted that a bulky hydrophobic residue is not conserved in HOIL-1L at the putative E2-binding loop. This leads to the possibility that if HOIL-1L binds the E2, it may bind it differently to the other RBR ligases. Therefore, without a high-resolution structure of the HOIL-1L RBR together with an E2 enzyme, a HOIL-1L E2-binding mutant cannot be reliably made. Failure to mutate all the correct residues could result in false positive or false negative results and would fail to address the model properly.</p></body></sub-article></article>